51
SUPPLEMENTARY INFORMATION For Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila Shuang Chang 1 , Steven M. Bray 1 , Zigang Li 2 , Daniela C. Zarnescu 3 , Chuan He 2 , Peng Jin 1 , and Stephen T. Warren 1,4 1 Department of Human Genetics, 4 Departments of Pediatrics and Biochemistry, Emory University School of Medicine, 615 Michael St. Suite 300, Atlanta, GA 30322, USA. 2 Department of Chemistry, The University of Chicago, GCIS 319B, 929 East 57th St., Chicago, IL 60637 USA. 3 Department of Molecular & Cellular Biology, University of Arizona, Life Sciences South 425 P. O. Box 210106 Tucson, AZ 85721, USA. Correspondence should be addressed to: Stephen T. Warren [email protected]

SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

SUPPLEMENTARY INFORMATION

For

Identification of small molecules rescuing fragile X syndrome phenotypes in

Drosophila

Shuang Chang1, Steven M. Bray1, Zigang Li2, Daniela C. Zarnescu3, Chuan He2, Peng

Jin1, and Stephen T. Warren1,4

1Department of Human Genetics, 4Departments of Pediatrics and Biochemistry, Emory

University School of Medicine, 615 Michael St. Suite 300, Atlanta, GA 30322, USA.

2Department of Chemistry, The University of Chicago, GCIS 319B, 929 East 57th St.,

Chicago, IL 60637 USA. 3Department of Molecular & Cellular Biology, University of

Arizona, Life Sciences South 425 P. O. Box 210106 Tucson, AZ 85721, USA.

Correspondence should be addressed to:

Stephen T. Warren [email protected]

Page 2: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

LF CF

Supplementary Fig. 1 Chang et al.

Supplementary Figure 1. Elevated glutamate in CF. HPLC amino acid analyses on aqueous extracts of CF and LF food preparations. The peak at position 16.63 indicates glutamate. The CF contained ~1.8-fold more glutamate than the LF.

Page 3: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

(a) L-Glutamic acid (b) Caged glutamate

(c) Caged glutamate,UV

(d) Caged glutamate,Acidic buffer,dark, 5 days

(e) Caged glutamate,Acidic buffer, light, 5 days

1 2 3

(f) Caged glutamate:1. Acidic buffer, light2. Acidic buffer, dark3. Water, dark

Supplementary Fig. 2 Chang et al;

Page 4: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Figure. 2. 1H NMR analysis shows release of free L-glutamic acid from caged glutamate into LF in the natural fly food environment. Caged glutamate (Sigma catalog # G3291) is stable in water, either in dark or under light, as proved by 1H NMR experiments. The 1H NMR spectrum of L-glutamic acid was shown in (a) and the 1H NMR spectrum of the caged glutamate was shown in (b). The spectrum of L-glutamic acid has a peak at ~2.3 ppm, which is not present in the spectrum of the caged glutamate. (c) A portion of aqueous caged glutamate solution was shined with hand-hold UV lamp. The solution turned from colorless into dark yellow. An NMR analysis clearly showed formation of L-glutamic acid as shown from the growth of the peak at ~2.3 ppm. (d, e) The caged glutamate was dissolved into an acidic buffer which is used for preparing the lab fly food LF (14 mL H2O, 200 µL ethanol, 80 µLpropionic acid, volume was calculated proportionally according to the LF recipe) and divided into two portions and kept either in dark (d) or under natural light (e) for five days, respectively. The NMR study shows no glutamate formation (<5% based on NMR sensitivity) from the sample kept in dark and clear formation of L-glutamic acid (peak at ~2.3 ppm, ~60-70% conversion based on NMR integration) for sample kept under natural light. (f) Color differences for the samples indicated in (d) and (e) compared with that of an aqueous solution of the caged glutamate. The working concentration is 2 mg caged glutamate dissolved in 250 µL water or buffer. Then the solvent was evaporated using lyophilizor and the residue was re-dissolved into D2O for NMR experiments. Red arrows point to L-glutamic acid representing peaks.

Page 5: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

0

25

50

75

100

125

Rel

ativ

e D

roso

phila

Via

bilit

y(%

)dFmr1 transgene+

dfmr1-

TM6C

;

dFmr1 transgene+

dfmr1-

dfmr1-

;

dfmr1-

TM6C

;++

dfmr1-

dfmr1-

;++

X

A:

B:

C:

D:A B C D

dFmr1 transgene

+ TM6C

dfmr1-;

dFmr1 transgene

+ TM6C

dfmr1-;

LF + Glutamate (10 µM)

*

p < 0.005

Supplementary Fig. 3 Chang et al;

Supplementary Figure. 3. dFmr1-mediated hypersensitivity to glutamate toxicity. A dfmr1+/-

strain carrying one copy of the dFmr1 transgene fragment was allowed to cross on LF food with additional glutamate (Glu = 10 µM). Progeny of each genotype were counted each day for ten consecutive days, and relative Drosophila viability was plotted by normalizing to heterozygous dfmr1flies without transgene, which was set as 100%. Four genotypes from progeny of the cross are indicated on the left. Error bars indicate S.E.M.; * = p < 0.005 student’s t-tests, two-tailed assuming equal variance.

Page 6: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

0

20

40

60

80

100

120

140

LF LF+Glu LF+Glu+LiClRel

ativ

e D

roso

phila

Via

bilit

y (%

)

Supplementary Fig. 4 Chang et al;

(5 mM)(10 µM) (10 µM)

Supplementary Figure. 4. Addition of 5mM LiCl rescues glutamate-stimulated toxicity in dfmr1 mutant flies. Equal numbers of heterozygous dfmr1 flies were allowed to produce embryos on LF supplemented with additional glutamate (10 µM) and glutamate (10 µM) + LiCl (5 mM). Progeny of homozygous and heterozygous dfmr1 flies were counted each day for ten consecutive days, and the percentage of viable homozygous (dfmr1-/-) flies was plotted. Error bars indicate S.E.M.

Page 7: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

No drug

No drug

Am

inobenztropine

GA

BA

MP

EP

Pilocarpine

Nipecotic

Acid

Creatinine

Pilocarpine

+ Scopolam

ine

Scopolam

ine

dfmr1-/-

0

20

40

60

80

100

120

140

160

dfmr1-/-

Futsch

β-actin

Nor

mal

ized

Rel

ativ

eFu

stch

Prot

ein

Leve

l (%

)

w1118w1118

No drug

No drug

Am

inobenztropine

GA

BA

MP

EP

Pilocarpine

Nipecotic

Acid

Creatinine

Pilocarpine

+ Scopolam

ine

Scopolam

ine

Supplementary Fig. 5 Chang et al;

Supplementary Figure. 5. Selected drug treatments partially rescue the overexpression of futsch protein in dfmr1-/-

flies. (a) Representative Western blot showing Futsch expression in control and homozygous (w1118 and dfmr1-/-) head lysates. Flies were raised on LF with or without drug supplements using the optimized dosages (Table 1). β-actin was used as a loading control. (b) Quantification of relative futsch protein level from multiple Western blots using Kodak Imaging System software. The quantifications were based on duplicate Western analyses obtained from triplicate collections of brain lysates from two separate drug treatments. The Futsch levels were first normalized to β-actin levels, then plotted as the percentage of change of each genotype/treatment compared to control (w1118 no drug), which was set as 100%. MPEP, GABA, pilocarpine, and aminobenztropine treatments showed significant differences in Futsch levels compared to homozygous flies (dfmr1-/- no drug) raised in the absence of the drugs. To test the specificity of the muscarinic receptors, a specific muscarinic receptor antagonist, scopolamine, was used to block pilocarpine activity and showed reversed effect on Futsch translation. Treatment of scopolamine alone had no effect. Error bars indicate S.E.M.; * = p < 0.05 student’s t-tests, two-tailed assuming equal variance.

Page 8: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

00.20.40.60.8

11.21.41.61.8

2

No Drug Glu+GABA

Futsch

β- actin

No drug Glu + GABA

w1118 w1118

Nor

mal

ized

Rel

ativ

e Fu

tsch

Pro

tein

Lev

el

(a) (b)

Supplementary Fig. 6 Chang et al;

Supplementary Figure. 6. futsch protein level is not affected in control fly heads upon drug treatment. (a) Representative Western blot showing Futsch expression in control fly (w1118) head lysates. Flies were raised on LF with or without glutamate (10 µM) and GABA (40 µM) supplements. b-actin was used as a loading control. (b) Quantification of relative futsch protein level from multiple Western blots using Kodak Imaging System software. The quantifications were based on duplicate Western analyses obtained from duplicate collections of brain lysates from two separate drug treatments. The Futsch levels were first normalized to β-actin levels, then plotted as the percentage of change compared to control (w1118 no drug), which was set as 100%. Error bars indicate S.E.M.

Page 9: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

αα α

α α

α

α

αα α

α

β β

β ββ

ββ

ββ β

β

γγ

γ

γ

γ γ

γγ

γ

γ

Normal

Creatinine (40 µM) Pilocarpine (5 µM) Nipecotic acid (40 µM)

α-missing

β-crossing β-crossing

β-broken ends β-misdirecting Over-branching

β-crossing

(a) (c) (d)

(e) (f) (g)

(b)

(i) (j) (k)

(h)

(m)

α

β

γ

GABA (40 µM)

(l)

No Drug (n=30)GABA (n=16)Nipecotic acid (n=15)

Creatinine (n=20)

Isopilocarpine (n=14)

0

20

40

60

80

100

Nor

mal

Bra

in M

B (%

)

* **

*

Supplementary Fig. 7 Chang et al;

Page 10: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Figure. 7. Drug treatments rescue abnormal mushroom bodies (MB) structure in the dfmr1 null fly brain. Brains from 0- to 2-day-old flies were immunostained with anti-Fas II antibody (ID4). The α, β and γ MB neuronal lobes are indicated. (a) Normal brain MB structure in control (w1118) flies. (b-h) Various MB structural abnormalities seen in null mutants (dfmr1-/-) raised on LF. Representative deficiencies are indicated by arrows. The abnormalities include: midline crossing by the βlobes; broken ends and misdirecting of the β lobes; over-branching or truncation of the β lobes; missing of one α lobe. (i-l) Drug treatments during development rescue the MB structural abnormalities associated with dfmr1 mutation. The neuronal lobes of the MBs were labeled with anti-Fas II antibody and appeared normal in these brains. Drug dosages used here were the optimal dosages determined in the viability assay. (m) The percentage of null flies (dfmr1-/-) with normal MB morphology after treatment with or without drugs. Three replicate drug treatments were performed, and the results were averaged. Error bars indicate S.E.M. over the three experiments (* = p < 0.005 student’s t-test, two-tailed assuming equal variance). The total number of flies scored is listed for each treatment.

Page 11: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.)

ID MOLENAME FORMULA MWt01503134 (-)-MENTHOL C10H20O 156.301900033 (+)METHAMPHETAMINE HYDROCHLORIDE C10H16ClN 185.701500425 (+)NAPROXEN C14H14O3 230.300100439 1(2)alpha-EPOXYDEOXYDIHYDROGEDUNIN C28H34O7 482.602300348 1-(2-METHOXYPHENYL)PIERAZINE HYDROCHLORIDE C11H17ClN2O 228.700100223 1,2alpha-EPOXYDEACETOXYDIHYDROGEDUNIN C26H32O7 456.501502116 1,2-DIMETHYLHYDRAZINE HYDROCHLORIDE C2H9ClN2 96.600231043 1,3,5-TRIMETHOXYBENZENE C9H12O3 168.200100355 1,3-DIDEACETYL-7-DEACETOXY-7-OXOKHIVORIN C26H34O7 458.600100378 1,3-DIDEACETYLKHIVORIN C28H38O8 502.602300286 1,3-DIHYDRO-5-METHYL-2H-1,4-BENZODIAZEPEN-2-ONE C10H10N2O 174.202300063 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE C16H24N4O2 304.400100358 1,7-DIDEACETOXY-1,7-DIOXO-3-DEACETYLKHIVORIN C26H32O7 456.500100585 1,7-DIDEACETOXY-1,7-DIOXOKHIVORIN C28H34O8 498.601504123 10-HYDROXYCAMTOTHECIN C20H16N2O5 364.400100002 11alpha-ACETOXYKHIVORIN C34H44O12 644.700107005 11-KETOROCKOGENIN ACETATE C31H46O7 530.700307045 11-OXOURSOLIC ACID ACETATE C32H48O5 512.700202175 12a-HYDROXY-5-DEOXYDEHYDROMUNDUSERONE C19H18O6 342.400200004 12a-HYDROXY-9-DEMETHYLMUNDUSERONE-8-CARBOXYLIC C19H16O9 388.300100604 13-METHYL-4,4-BISNOR-8,11,13-PODOCARPATRIEN-3-ONE C16H20O 228.300100648 14-METHOXY-4,4-BISNOR-4,8,11,13-PODOCARPATETRAEN-3- C16H18O2 242.300300166 15-NORCARYOPHYLLEN-3-ONE C14H22O 206.300100158 16-DEOXOMEXICANOLIDE 16-METHYL ETHER C28H36O7 484.601500989 18alpha-GLYCYRRHETINIC ACID C30H46O4 470.700100562 1-DEACETOXY-1-OXO-3,7-DIDEACETYLKHIVORIN C26H34O7 458.602300329 1-METHYLXANTHINE C6H6N4O2 166.101503641 1-PHENYLBIGUANIDE HYDROCHLORIDE C8H12ClN5 213.702300253 1R,2S-PHENYLPROPYLAMINE C9H13NO 151.201501009 1R,9S-HYDRASTINE C21H21NO6 383.401500687 1S,9R-beta-HYDRASTINE C21H21NO6 383.401500156 1S-CAMPHOR C10H16O 152.201503647 2-(2,6-DIMETHOXYPHENOXYETHYL)AMINOMETHYL-1,4- C19H24ClNO5 381.901900011 2-(METHYLAMINO)PROPIOPHENONE HYDROCHLORIDE C10H14ClNO 199.700201507 2',2'"-BISEPIGALLOCATECHIN DIGALLATE C44H34O22 914.700201506 2',2'-BISEPIGALLOCATECHIN MONOGALLATE C37H30O18 762.600330050 2,2-DICHLOROPROPIONIC ACID C3H4Cl2O2 143.000200412 2,3,4'-TRIHYDROXY-4-METHOXYBENZOPHENONE C14H12O5 260.200240584 2,3,4'-TRIHYDROXYBENZOPHENONE C13H10O4 230.200100290 2,3-DIHYDROISOGEDUNIN C28H36O7 484.600211155 2,3-METHANO-7,2'-DIMETHOXYFLAVANONE C18H16O4 296.300330042 2,4,5-TRICHLOROPHENOXYACETIC ACID C8H5Cl3O3 255.500330049 2,4,5-TRICHLOROPHENOXYACETIC ACID, ISOOCTYL ESTER C16H21Cl3O3 367.700330046 2,4,5-TRICHLOROPHENOXYACETIC ACID, METHYL ESTER C9H7Cl3O3 269.500330040 2,4-DICHLOROPHENOXYACETIC ACID C8H6Cl2O3 221.000330048 2,4-DICHLOROPHENOXYACETIC ACID, ISOOCTYL ESTER C16H22Cl2O3 333.300330044 2,4-DICHLOROPHENOXYACETIC ACID, METHYL ESTER C9H8Cl2O3 235.100330041 2,4-DICHLOROPHENOXYBUTYRIC ACID C10H10Cl2O3 249.1

Page 1

Page 12: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00330045 2,4-DICHLOROPHENOXYBUTYRIC ACID, METHYL ESTER C11H12Cl2O3 263.100200258 2',4'-DIHYDROXYCHALCONE 4'-GLUCOSIDE C21H22O8 402.400330008 2,4-DINITROPHENOL C6H4N2O5 184.100210599 2,5-DIHYDROXY-3,4-DIMETHOXY-4'-ETHOXY C17H18O6 318.301600716 2,6-DI-t-BUTYL-4-METHYLPHENOL (BHT) C15H24O 220.400210738 2-DEMETHYLAPIOLIC ACID C9H8O6 212.200200183 2-ETHOXYCARBONYL-2-HYDROXY-5,7- C20H20O7 372.402300188 2-HYDROXY-4-(2-HYDROXY-3-t-BUTYLAMINOPROPOXY)- C14H22ClN3O 315.800300119 2-HYDROXY-5(6)EPOXY-TETRAHYDROCARYOPHYLLENE C15H26O2 238.400100676 2-HYDROXY-8-METHOXYLEPIDINE C11H11NO2 189.200240651 2-HYDROXYXANTHONE C13H8O3 212.200240497 2-ISOPRENYL-3-HYDROXY-5-METHYL-a-PYRONE C11H14O3 194.200100756 2-ISOPROPYL-3-METHOXYCINNAMIC ACID C13H16O3 220.301504225 2-MERCAPTOBENZOTHIAZOLE (AG-63; Dermacid) C7H5NS2 167.300300111 2-METHOXY-5(6)EPOXY-TETRAHYDROCARYOPHYLLENE C16H28O2 252.400201310 2'-METHOXYFORMONETIN C17H14O5 298.300211066 2-METHOXYRESORCINOL C7H8O3 140.100240736 2-METHOXYXANTHONE C14H10O3 226.200100599 2-METHYL GRAMINE C12H16N2 188.301504091 2-METHYL-3-HYDROXYETHYLENEPYRAN-4-ONE C8H8O3 152.201504227 2-PHENYLBUTYRIC ACID C10H12O2 164.201504090 2-PROPYL-3-HYDROXYETHYLENEPYRAN-4-ONE C10H12O3 180.201503973 2-THIOURACIL C4H4N2OS 128.200100435 3,16-DIDEOXYMEXICANOLIDE-3alpha-DIOL C27H36O7 472.600100359 3,16-DIDEOXYMEXICANOLIDE-3beta-DIOL C27H36O7 472.600211458 3,4,5-TRIMETHOXYCINNAMALDEHYDE C12H14O4 222.200240429 3,4-DIDESMETHYL-5-DESHYDROXY-3'-ETHOXYSCLEROIN C15H14O5 274.300240828 3,4-DIMETHOXYDALBERGIONE C17H16O4 284.301500734 3,4'-DIMETHOXYFLAVONE C17H14O4 282.301900009 3,4-METHYLENEDIOXYAMPHETAMINE HYDROCHLORIDE C10H14ClNO2 215.701900007 3,4-METHYLENEDIOXYMETHAMPHETAMINE HYDROCHLORIDE C11H16ClNO2 229.701504129 3,5-DIMETHOXYFLAVONE C17H14O4 282.301503631 3,5-DINITROCATECHOL C6H4N2O6 200.101504130 3,7-DIHYDROXYFLAVONE C15H10O4 254.201500737 3,7-DIMETHOXYFLAVONE C17H14O4 282.300300118 3,7-EPOXYCARYOPHYLLAN-6-OL C15H26O2 238.400300132 3,7-EPOXYCARYOPHYLLAN-6-ONE C15H24O2 236.400240871 3-ACETOXY-28-OLEANONIC ACID C32H52O4 500.800100580 3-ACETOXYPREGN-16-EN-12,20-DIONE C23H32O4 372.500100205 3alpha-ACETOXYDIHYDRODEOXYGEDUNIN C30H40O7 512.600100114 3alpha-HYDROXY-3-DEOXYANGOLENSIC ACID METHYL ESTER C27H36O7 472.600100618 3alpha-HYDROXY-4,4-BISNOR-8,11,13-PODOCARPATRIENE C15H20O 216.300100190 3-alpha-HYDROXYDEOXYGEDININ C28H36O6 468.601503694 3-AMINOBENZAMIDE C7H8N2O 136.200300106 3-AMINO-beta-PINENE C10H18ClN 187.701501125 3-AMINOPROPANESULPHONIC ACID C3H9NO3S 139.200102034 3beta,7beta-DIACETOXYDEOXODEACETOXYDEOXY- C30H40O7 512.600100304 3beta-ACETOXY-23-BROMO- C29H41BrO5 549.600100497 3beta-ACETOXYDEOXODIHYDROGEDUNIN C30H40O8 528.600100651 3beta-ACETOXYDEOXYANGOLENSIC ACID, METHYL ESTER C29H38O8 514.600100586 3BETA-CHLOROANDROSTANONE C19H29ClO 308.900102035 3beta-HYDROXYDEOXODIHYDRODEOXYGEDUNIN C28H38O6 470.6

Page 2

Page 13: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00100492 3beta-HYDROXYDEOXODIHYDROGEDUNIN C28H38O7 486.600100901 3beta-HYDROXYDEOXYDESACETOXY-7-OXOGEDUNIN C26H32O6 440.500100126 3-CHLORO-8beta-HYDROXYCARAPIN, 3,8-HEMIACETAL C27H31ClO7 503.000100013 3-DEACETYLKHIVORIN C30H40O9 544.600100201 3-DEOXO-3beta-ACETOXYDEOXYDIHYDROGEDUNIN C30H40O7 512.600100138 3-DEOXO-3beta-HYDROXY-8,14-DIHYDROMEXICANOLIDE-14(15)- C27H34O7 470.600100222 3-DEOXO-3beta-HYDROXYMEXICANOLIDE 16-ENOL ETHER C28H36O7 484.600100096 3-DEOXY-3beta-HYDROXYANGOLENSIC ACID METHYL ESTER C27H36O7 472.601504036 3-DESHYDROXYSAPPANOL TRIMETHYL ETHER C19H22O5 330.400201083 3-DESMETHYL-5-DESHYDROXYSCLEROIN C14H12O4 244.200100243 3-HYDROXY-5,6-DEHYDRODINORTOTAROL METHYL ETHER C19H26O2 286.402300336 3-HYDROXYBENZYLHYDRAZINE DIHYDROCHLORIDE C7H12Cl2N2O 211.100211538 3-HYDROXYCOUMARIN C9H6O3 162.101501012 3-HYDROXYFLAVONE C15H10O3 238.201503625 3-HYDROXYMETHYL-b-CARBOLINE C12H10N2O 198.201600919 3-METHOXYCATECHOL C7H8O3 140.101503635 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE C10H10N2O 174.200330007 3-METHYLCHOLANTHRENE C21H16 268.400200640 3-METHYLORSELLINIC ACID C9H10O4 182.201504182 3-METHYLXANTHINE C6H6N4O2 166.100300110 3-NOR-3-OXOPANASINSAN-6-OL C14H22O2 222.300307047 3-OXOURSAN(28-13)OLIDE C30H44O3 452.700300160 3-PINANONE OXIME C10H17NO 167.300211031 4(5)a-EPOXY-4,5-DIHYDROSANTONIN C15H18O4 262.300201448 4,4'-DIMETHOXYDALBERGIONE C17H16O4 284.301502081 4,6-DICHLOROINDOLE-2-CARBOXYLIC ACID C9H5Cl2NO2 230.100210554 4,7-DIMETHOXYFLAVONE C17H14O4 282.302300086 4-CHLOROPHENYLGUANIDINE HYDROCHLORIDE C7H9Cl2N3 206.101600759 4-HYDROXY-6-METHYLPYRAN-2-ONE C6H6O3 126.100200798 4'-HYDROXYDALBERGIONE C15H12O3 240.301601011 4-METHOXY-4'-ACETOXYDALBERGIONE C18H16O5 312.300201092 4-METHOXYDALBERGIONE C16H14O3 254.301500730 4-METHYLDAPHNETIN C10H8O4 192.201500729 4-METHYLESCULETIN C10H8O4 192.201502074 4-NAPHTHALIMIDOBUTYRIC ACID C16H13NO4 283.300330085 4-NONYLPHENOL C15H24O 220.401504131 5,2'-DIHYDROXYFLAVONE C15H10O4 254.201500738 5,2'-DIMETHOXYFLAVONE C17H14O4 282.300211227 5,4'-DIMETHOXYFLAVONE C17H14O4 282.301502062 5,7-DICHLOROKYNURENIC ACID C10H5Cl2NO3 258.100240565 5,7-DIHYDROXYISOFLAVONE C15H10O4 254.200100646 5alpha-12-METHOXY-4,4-BISNOR- C16H20O2 244.301501126 5-AMINOPENTANOIC ACID HYDROCHLORIDE C5H12ClNO2 153.601502111 5-AZACYTIDINE C8H12N4O5 244.201502057 5-CHLOROINDOLE-2-CARBOXYLIC ACID C9H6ClNO2 195.601501189 5-FLUORO-5'-DEOXYURIDINE C9H11FN2O6 262.201502092 5-FLUOROINDOLE-2-CARBOXYLIC ACID C9H6FNO2 179.200300049 5-HYDROXYIMINOISOCARYOPHYLLENE C15H23NO 233.401502153 5-NITRO-2-PHENYLPROPYLAMINOBENZOIC ACID [NPPB] C16H16N2O4 300.301504132 6,3'-DIMETHOXYFLAVONE C17H14O4 282.301500741 6,4'-DIMETHOXYFLAVONE C17H14O4 282.300100056 6-ACETOXY-ANGOLENSIC ACID METHYL ESTER C29H36O9 528.6

Page 3

Page 14: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01503254 6alpha-METHYLPREDNISOLONE ACETATE C24H32O6 416.500100058 6-HYDROXYANGOLENSIC ACID METHYL ESTER C27H34O8 486.600210560 6-HYDROXYGENISTEIN C15H10O6 286.200200781 7,2',4'-TRIHYDROXYISOFLAVONE C15H10O5 270.200210556 7,2'-DIMETHOXY-4',5'-METHYLENEDIOXY-ISOFLAVONE C18H14O6 326.301500742 7,2'-DIMETHOXYFLAVONE C17H14O4 282.300201187 7,4'-DIMETHOXYISOFLAVONE C17H14O4 282.300201315 7,8-DIHYDROXYFLAVONE C15H10O4 254.200100638 7beta-HYDROXY-7-DESACETOXYKHIVORINIC ACID, METHYL C28H40O10 536.602300318 7-CHLOROETHYLTHEOPHYLLINE C9H11ClN4O2 242.701502059 7-CHLOROKYNURENIC ACID C10H6ClNO3 223.600100170 7-DEACETOXY-7-OXODEOXYGEDUNIN C26H30O5 422.500100048 7-DEACETOXY-7-OXOKHIVORIN C30H38O9 542.601602020 7-DEACETYLDIHYDROGEDUNIN C26H34O6 442.600100014 7-DEACETYLKHIVORIN C30H40O9 544.600100549 7-DEACETYLKHIVORINIC ACID C27H38O10 522.600100146 7-DESACETOXY-6,7-DEHYDROGEDUNIN C26H30O5 422.500201508 7-DESHYDROXYPYROGALLIN-4-CARBOXYLIC ACID C12H8O6 248.200210522 7-DESOXYPURPUROGALLIN-4-CARBOXYLIC ACID, C16H16O6 304.300100398 7-EPIKHIVORIN C32H42O10 586.700201309 7-HYDROXY-2'-METHOXYISOFLAVONE C16H12O4 268.300201185 7-HYDROXY-8,4'-DIMETHOXYISOFLAVONE C17H14O5 298.302300357 7-HYDROXYETHYLTHEOPHYLLINE C9H12N4O3 224.200300104 7-NOR-8-OXOCARYOPHYLLENYLSUCCINIC ANHYDRIDE C18H24O4 304.400100156 8beta-HYDROXYCARAPIN C27H32O8 484.600100105 8beta-HYDROXYCARAPIN, 3,8-HEMIACETAL C27H32O8 484.602300193 8-CYCLOPENTYLTHEOPHYLLINE C12H16N4O2 248.300300060 8-HYDROXY-15,16-BISNOR-11-LABDEN-13-ONE C18H30O2 278.400240567 8-IODOCATECHIN TETRAMETHYL ETHER C19H21IO6 472.302300104 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE C13H15ClN2 234.700102151 ABBEOKUTONE C18H28O3 292.400300050 ABIENOL C20H34O 290.500350005 ABIETANOL C20H32O 288.501502229 ABIETIC ACID C20H30O2 302.501502236 ABRINE(L) C12H14N2O2 218.301502234 ABSCISIC ACID (cis,trans; +/-) C15H20O4 264.300200833 ACACETIN DIACETATE C20H16O7 368.300200499 ACACETIN C16H12O5 284.301500665 ACEBUTOLOL HYDROCHLORIDE C18H29ClN2O 372.901501124 ACECLIDINE HYDROCHLORIDE C9H16ClNO2 205.701500666 ACEMETACIN C21H18ClNO6 415.800330059 ACEPHATE C4H10NO3PS 183.201500101 ACETAMINOPHEN C8H9NO2 151.201501170 ACETAMINOSALOL C15H13NO4 271.301501173 ACETANILIDE C8H9NO 135.201500616 ACETARSOL C8H10AsNO5 275.101500102 ACETAZOLAMIDE C4H6N4O3S2 222.200330089 ACETOCHLOR C14H20ClNO2 269.801500103 ACETOHYDROXAMIC ACID C2H5NO2 75.100300610 ACETOSYRINGONE C10H12O4 196.201503969 ACETOXOLONE C32H48O5 512.701504142 ACETRIZOIC ACID C9H6I3NO3 556.9

Page 4

Page 15: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00300549 ACETYL ISOGAMBOGIC ACID C40H46O9 670.801502089 ACETYLCARNITINE C8H16ClNO4 225.701500104 ACETYLCHOLINE C7H16ClNO2 181.701500105 ACETYLCYSTEINE C5H9NO3S 163.201500715 ACETYLGLUCOSAMINE C8H15NO6 221.201500703 ACETYLGLUTAMIC ACID C7H11NO5 189.201502001 ACETYL-L-LEUCINE C8H15NO3 173.201500700 ACETYLSEROTONIN C12H14N2O2 218.301500702 ACETYLTRYPTOPHAN C13H14N2O3 246.301500699 ACETYLTRYPTOPHANAMIDE C13H15N3O2 245.301503045 ACEXAMIC ACID C8H15NO3 173.201502002 ACIVICIN C5H7ClN2O3 178.601503072 ACLACINOMYCIN A1 C42H53NO15 811.900310001 ACONITIC ACID C6H6O6 174.101500655 ACONITINE C34H47NO11 645.801500618 ACRIFLAVINIUM HYDROCHLORIDE C14H14ClN3 259.700330001 ACTINOMYCIN D C64H88N10O1 1253.500210477 ACTINONIN C19H35N3O5 385.501503603 ACYCLOVIR C8H11N5O3 225.201500807 ADENINE C5H5N5 135.101500667 ADENOSINE PHOSPHATE C10H14N5O7 347.201500107 ADENOSINE C10H13N5O4 267.201503073 ADIPHENINE HYDROCHLORIDE C20H26ClNO2 347.900310002 ADONITOL C5H12O5 152.101500274 ADRENALINE BITARTRATE C13H19NO9 333.301500901 AESCULIN C15H16O9 340.301503982 AGMATINE SULFATE C5H16N4O4S 228.301501024 AJMALICINE C21H24N2O3 352.400350011 AJMALINE DIACETATE C24H30N2O4 410.501500656 AJMALINE C20H26N2O2 326.400200022 AKLAVINE HYDROCHLORIDE C30H36ClNO1 606.101503014 AKLOMIDE C7H5ClN2O3 200.600330043 ALACHLOR C14H20ClNO2 269.801504136 ALAPROCLATE C13H18ClNO2 255.701503903 ALBENDAZOLE C12H15N3O2 265.301500711 ALBIZZIN C4H9N3O3 147.101500677 ALBUTEROL C13H21NO3 239.300330061 ALDICARB C7H14N2O2S 190.300330080 ALDRIN C12H8Cl6 364.901503074 ALEXIDINE HYDROCHLORIDE C26H58Cl2N1 581.701400367 ALFALONE METHYL ETHER C18H16O5 312.301503424 ALFAXALONE C21H32O3 332.500210850 ALIZARIN C14H8O4 240.201500801 ALLANTOIN C4H6N4O3 158.100100303 ALLOPREGNANOLONE C21H34O2 318.501500108 ALLOPURINOL C5H4N4O 136.101500802 ALLOXAN C4H2N2O4 142.101503427 ALOIN C21H22O10 434.401800013 alpha-AMYRIN ACETATE C32H52O2 468.801800029 alpha-AMYRIN BENZOATE C37H54O2 530.801502095 alpha-CYANO-3-HYDROXYCINNAMIC ACID C10H7NO3 189.201502096 alpha-CYANO-4-HYDROXYCINNAMIC ACID C10H7NO3 189.2

Page 5

Page 16: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01504015 alpha-MANGOSTIN C24H26O6 410.502300312 alpha-METHYL-L-TYROSINE C10H13NO3 195.200310039 alpha-TOCHOPHEROL C29H50O2 430.700310040 alpha-TOCHOPHERYL ACETATE C31H52O3 472.801501028 alpha-YOHIMBINE C21H26N2O3 354.501500733 ALPINETIN METHYL ETHER C17H16O4 284.302300166 ALPRENOLOL C15H24ClNO2 285.801502053 ALRESTATIN C14H9NO4 255.201500804 ALTHIAZIDE C11H14ClN3O 383.901503065 ALTRETAMINE C9H18N6 210.301500109 ALVERINE CITRATE C27H37NO6 471.601500110 AMANTADINE HYDROCHLORIDE C10H18ClN 187.700100530 AMBELLINE C18H21NO5 331.400310003 AMBRETTOLIDE C16H28O2 252.401503080 AMBROXOL HYDROCHLORIDE C13H19Br2Cl 414.601503816 AMCINONIDE C28H35FO7 502.601504170 AMENTOFLAVONE C30H18O10 538.501503081 AMIFOSTINE C5H15N2O3P 214.201500111 AMIKACIN SULFATE C22H47N5O21 781.801500112 AMILORIDE HYDROCHLORIDE C6H9Cl2N7O 266.101500810 AMINACRINE C13H10N2 194.202300334 AMINOBENZTROPINE C21H26N2O 322.501500114 AMINOCAPROIC ACID C6H13NO2 131.201502130 AMINOCYCLOPROPANECARBOXYLIC ACID C4H7NO2 101.101500115 AMINOGLUTETHIMIDE C13H16N2O2 232.301503069 AMINOHIPPURIC ACID C9H10N2O3 194.201503041 AMINOHYDROXYBUTYRIC ACID C4H9NO3 119.101504184 AMINOLEVULINIC ACID HYDROCHLORIDE C5H10ClNO3 167.601500621 AMINOPHENAZONE C11H13N3O 203.201502115 AMINOPTERIN C19H20N8O5 440.401501130 AMINOPYRIDINE C5H6N2 94.102300167 AMINOREX C9H10N2O 162.201503017 AMINOTHIAZOLE C3H4N2S 100.102300165 AMIODARONE HYDROCHLORIDE C25H30ClI2N 681.801503083 AMIPRILOSE C14H28ClNO6 341.801500117 AMITRIPTYLINE HYDROCHLORIDE C20H24ClN 313.901900012 AMOBARBITAL SODIUM C11H17N2Na 248.301500119 AMODIAQUINE DIHYDROCHLORIDE C20H24Cl3N3 428.802300161 AMOXEPINE C17H16ClN3O 313.801500120 AMOXICILLIN C16H19N3O5 365.401500122 AMPHOTERICIN B C47H73NO17 924.101500123 AMPICILLIN SODIUM C16H18N3Na 371.401500124 AMPROLIUM C14H20Cl2N4 315.201503084 AMRINONE C10H9N3O 187.201503256 AMSACRINE C22H20N2O3 392.501502244 AMYGDALIN C20H27NO11 457.401504156 ANABASAMINE HYDROCHLORIDE C16H20ClN3 289.800310004 ANABASINE HYDROCHLORIDE C10H15ClN2 198.701504137 ANCITABINE HYDROCHLORIDE C9H12ClN3O4 261.700100003 ANDIROBIN C27H32O7 468.600300532 ANDROGRAPHOLIDE C20H30O5 350.500100569 ANDROST-2-EN-17-ONE C19H28O 272.4

Page 6

Page 17: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01503675 ANDROSTERONE SODIUM SULFATE C19H29NaO5 392.501503705 ANETHOLE C10H12O 148.200100054 ANGOLENSIC ACID, METHYL ESTER C27H34O7 470.600100616 ANGOLENSIN (R) C16H16O4 272.300200457 ANHYDROBRAZILIC ACID C12H10O5 234.201503078 ANIRACETAM C12H13NO3 219.201502198 ANISINDIONE C16H12O3 252.300300047 ANISODAMINE C17H23NO4 305.401503906 ANISOMYCIN C14H19NO4 265.301500126 ANTAZOLINE PHOSPHATE C17H22N3O4 363.401503674 ANTHERAXANTHIN C40H56O3 584.900100005 ANTHOTHECOL C28H32O7 480.601502068 ANTHRACENE-9-CARBOXYLIC ACID C15H10O2 222.201500127 ANTHRALIN C14H10O3 226.201502103 ANTHRAQUINONE C14H8O2 208.200200110 ANTIAROL C9H12O4 184.201502108 ANTIMYCIN A (A1 shown) C27H38N2O9 534.601500128 ANTIPYRINE C11H12N2O 188.201504155 APHYLLIC ACID C15H26N2O2 266.400200846 APIGENIN C15H10O5 270.200350025 APIIN C26H28O14 564.501500129 APOMORPHINE HYDROCHLORIDE C17H18ClNO2 303.800211949 APOTOXICAROL C18H14O7 342.300380002 APULEISIN C17H14O8 346.300380001 APULEITRIN C19H18O9 390.300211539 ARABITOL C5H12O5 152.101504138 ARACHIDONIC ACID C20H32O2 304.500300539 ARBUTIN C12H16O7 272.301500706 ARCAINE SULFATE C6H18N6O4S 270.301500680 ARECOLINE HYDROBROMIDE C8H14BrNO2 236.101502233 ARISTOLOCHIC ACID C17H11NO7 341.301500659 ARTEMISIN C16H20O4 276.301503042 ARTEMISININ C15H22O5 282.301504180 ASARININ (-) C20H18O6 354.401502230 ASCORBIC ACID C6H8O6 176.100210863 ASPERGILLIC ACID C12H20N2O2 224.300211363 ASPIRIN C9H8O4 180.201502235 ASTAXANTHIN C40H52O4 596.902300094 ASTEMIZOLE C28H31FN4O 458.601501127 ATENOLOL C14H22N2O3 266.301503722 ATORVASTATIN C33H33CaFN 582.701504210 ATOVAQUONE C22H19ClO3 366.801502117 ATRACTYLOSIDE POTASSIUM C30H44K2O16 803.000200034 ATRANORIN C19H18O8 374.401504133 ATRARIC ACID C10H12O4 196.200330029 ATRAZINE C8H14ClN5 215.701500131 ATROPINE C17H25NO7S 387.501500186 AUREOMYCIN C22H23ClN2O 478.901504139 AUSTRICINE C15H18O4 262.301502260 AVERMECTIN B1 C48H72O14 873.101504190 AVOBENZONE C20H22O3 310.400240560 AVOCADENE ACETATE C19H36O4 328.5

Page 7

Page 18: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00240932 AVOCADENE C17H34O3 286.500240929 AVOCADYNE ACETATE C19H34O4 326.500210025 AVOCATIN A C19H34O4 326.500211552 AVOCATIN B C17H32O3 284.401503802 AZADIRACHTIN C35H44O16 720.701502113 AZASERINE C5H7N3O4 173.101500133 AZATHIOPRINE C9H7N7O2S 277.301500648 AZELAIC ACID C9H16O4 188.200330013 AZINPHOS METHYL C10H12N3O3 317.301503101 AZLOCILLIN SODIUM C20H22N5Na 483.501501172 AZOBENZENE C12H10N2 182.201503102 BACAMPICILLIN HYDROCHLORIDE C21H28ClN3O 502.001500134 BACITRACIN C66H103N17O 1422.701500135 BACLOFEN C10H12ClNO2 213.701504127 BAICALEIN TRIMETHYL ETHER C18H16O5 312.301504002 BAICALEIN C15H10O5 270.201503983 BATYL ALCOHOL C21H44O3 344.601503984 BEBEERINE C35H36N2O7 596.701500812 BECANAMYCIN SULFATE C18H39N5O14 581.601500136 BECLOMETHASONE DIPROPIONATE C28H37ClO7 521.100330063 BENDIOCARB C11H13NO4 223.201503104 BENDROFUMETHIAZIDE C15H14F3N3O 421.401500669 BENFLUOREX HYDROCHLORIDE C19H21ClF3N 387.800330033 BENFLURALIN C13H16F3N3O 335.301503105 BENFOTIAMINE C19H23N4O6 466.501500137 BENSERAZIDE HYDROCHLORIDE C10H16ClN3O 293.700330039 BENTAZON C10H12N2O3 240.301503610 BENZALKONIUM CHLORIDE C22H40ClN 354.001500138 BENZETHONIUM CHLORIDE C27H42ClNO2 448.100330005 BENZO[a]PYRENE C20H12 252.301500139 BENZOCAINE C9H11NO2 165.201500141 BENZTHIAZIDE C15H14ClN3O 431.901500142 BENZTROPINE C21H27NO5S 405.501503002 BENZYL BENZOATE C14H12O2 212.301503006 BENZYL ISOTHIOCYANATE C8H7NS 149.200330087 BENZYLBUTYLPHTHALATE C19H20O4 312.401503106 BEPRIDIL HYDROCHLORIDE C24H35ClN2O 403.001501019 BERBAMINE HYDROCHLORIDE C37H42Cl2N2 681.701500811 BERBERINE CHLORIDE C20H18ClNO4 371.800300546 BERGAPTENE C12H8O4 216.201500819 BERGENIN C14H16O9 328.300100552 beta-AMYRIN ACETATE C32H52O2 468.800100360 beta-AMYRIN C30H50O 426.701500143 beta-CAROTENE C40H56 536.900300105 beta-CARYOPHYLLENE ALCOHOL C15H26O 222.401504030 beta-ESCIN C55H86O24 1131.301500670 BETAHISTINE HYDROCHLORIDE C8H14Cl2N2 209.101503007 BETAINE HYDROCHLORIDE C5H12ClNO2 153.601500145 BETAMETHASONE VALERATE C27H37FO6 476.601500144 BETAMETHASONE C22H29FO5 392.501503234 BETA-PROPIOLACTONE C3H4O2 72.100107022 beta-SITOSTEROL C29H50O 414.7

Page 8

Page 19: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00211232 beta-TOXICAROL C23H22O7 410.401500146 BETHANECHOL CHLORIDE C7H17ClN2O2 196.701501018 BETONICINE C7H13NO3 159.201500815 BETULIN C30H50O2 442.701504081 BETULINIC ACID C29H46O3 442.701502046 BEZAFIBRATE C19H20ClNO4 361.801500821 BICUCULLINE (+) C20H17NO6 367.401500857 BILIRUBIN C33H36N4O6 584.701500830 BILIVERDIN C33H34N4O6 582.700211906 BILOBETIN C31H20O10 552.500300601 BIOCHANIN A DIACETATE C20H16O7 368.310100003 BIOCHANIN A C16H12O5 284.310100004 BIOCHANIN A, MONOMETHYL ETHER C17H14O5 298.301503009 BIOTIN C10H16N2O3 244.300307058 BISABOLOL ACETATE C17H28O2 264.400307057 BISABOLOL C13H22O 194.301500147 BISACODYL C22H19NO4 361.401500148 BITHIONOL C12H4Cl4Na2 400.010101011 BIXIN C25H30O4 394.501503692 BLEOMYCIN (bleomycin B2 shown) C58H94N20O2 1615.801500862 BOLDINE C19H21NO4 327.401504206 BOVINOCIDIN C3H5NO4 119.100200463 BRAZILEIN C16H12O4 268.300200012 BRAZILIN C16H14O5 286.301502018 BRETYLIUM TOSYLATE C18H24BrNO3 414.401503107 BROMHEXINE HYDROCHLORIDE C14H21Br2Cl 412.600300053 BROMO-3-HYDROXY-4-(SUCCIN-2-YL)-CARYOLANE gamma- C19H27BrO4 399.301500151 BROMOCRIPTINE MESYLATE C33H44BrN5O 750.701503108 BROMOPRIDE C14H22BrN3O 344.301503985 BROMPHENIRAMINE MALEATE C20H23BrN2O 435.301500623 BROXYQUINOLINE C9H5Br2NO 303.001500822 BRUCINE C23H26N2O4 394.501503043 BUCLADESINE C18H24N5O8 469.401500813 BUDESONIDE C25H34O6 430.501502003 BUFEXAMAC C12H17NO3 223.301502004 BUMETANIDE C17H20N2O5 364.401503818 BUPIVACAINE HYDROCHLORIDE C18H29ClN2O 324.901504174 BUPROPION C13H18ClNO 239.700300517 BURASAINE C21H23N2O7 415.402300173 BUSPIRONE HYDROCHLORIDE C21H32ClN5O 422.000100006 BUSSEIN C43H54O18 858.901500152 BUSULFAN C6H14O6S2 246.301503914 BUTACAINE C18H30N2O2 306.501900015 BUTALBITAL C11H16N2O3 224.301500767 BUTAMBEN C11H15NO2 193.201504097 BUTENAFINE HYDROCHLORIDE C23H28ClN 353.901500818 BUTIROSIN DISULFATE C21H45N5O20 751.701504140 BUTOCONAZOLE C19H17Cl3N2 411.801800172 BYSSOCHLAMIC ACID C18H20O6 332.401503947 CACODYLIC ACID C2H7AsO2 138.001502227 CADAVERINE SULFATE C3H12N2O4S 172.200300055 CADIN-4-EN-10-OL C15H26O 222.4

Page 9

Page 20: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00330006 CADMIUM ACETATE C4H6CdO4 230.501503986 CAFESTOL ACETATE C22H30O4 358.501504001 CAFESTOL C20H28O3 316.401503987 CAFFEIC ACID C9H8O4 180.201500155 CAFFEINE C8H10N4O2 194.201500763 CALCEIN C30H26N2O13 622.501503905 CALCIMYCIN C29H37N3O6 523.600300391 CALPLOICIN METHYL ETHER C18H15Cl3O5 417.701502232 CAMPTOTHECIN C20H16N2O4 348.401500833 CANAVANINE C5H12N4O3 176.201500828 CANRENOIC ACID, POTASSIUM SALT C22H29KO4 396.601500814 CANTHARIDIN C10H12O4 196.201504204 CANTHAXANTHIN C40H52O2 564.901500157 CAPREOMYCIN SULFATE C25H46N14O1 766.801500682 CAPTOPRIL C9H15NO3S 217.300100008 CARAPIN C27H32O7 468.600100102 CARAPIN-8(9)-ENE C27H30O7 466.501500158 CARBACHOL C6H15ClN2O2 182.701500159 CARBAMAZEPINE C15H12N2O 236.301500160 CARBENICILLIN DISODIUM C17H16N2Na2 422.401502005 CARBENOXOLONE SODIUM C34H48Na2O7 614.701501129 CARBETAPENTANE CITRATE C26H39NO10 525.601502150 CARBIDOPA C10H14N2O4 226.201500161 CARBINOXAMINE MALEATE C20H23ClN2O 406.900330057 CARBOFURAN C12H15NO3 221.301502106 CARBOPLATIN C6H12N2O4Pt 371.301500162 CARISOPRODOL C12H24N2O4 260.301500817 CARMINIC ACID C22H20O14 508.401503110 CARMUSTINE C5H9Cl2N3O2 214.101500624 CARNITINE CHLORIDE C7H16ClNO3 197.701504120 CARNOSIC ACID C20H28O4 332.401500944 CARNOSINE C9H14N4O3 226.201502006 CARPROFEN C15H12ClNO2 273.701500832 CARYLOPHYLLENE OXIDE C14H22O 206.301500842 CARYOPHYLLENE [t(-)] C14H22 190.300300148 CARYOPHYLLENYL ACETATE C17H26O2 262.401600537 CATECHIN PENTAACETATE C25H24O11 500.500210235 CATECHIN PENTABENZOATE C50H34O11 810.800210220 CATECHIN TETRAMETHYLETHER C19H22O6 346.400290030 CEAROIN C14H12O4 244.200100009 CEDRELONE C26H30O5 422.500307059 CEDROL C15H26O 222.400310015 CEDRYL ACETATE C17H28O2 264.401500771 CEFACLOR C15H14ClN3O 367.801500163 CEFADROXIL C16H17N3O5 363.401502041 CEFAMANDOLE NAFATE C19H17N6Na 512.501502038 CEFAMANDOLE SODIUM C18H17N6Na 484.501500164 CEFAZOLIN SODIUM C14H13N8Na 476.501502040 CEFMETAZOLE SODIUM C15H16N7Na 493.501502042 CEFOPERAZOLE SODIUM C25H26N9Na 667.701500165 CEFOTAXIME SODIUM C16H16N5Na 477.501502031 CEFOXITIN SODIUM C16H16N3Na 449.4

Page 10

Page 21: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01502029 CEFSULODIN SODIUM C22H19N4Na 554.501503111 CEFTRIAXONE SODIUM C18H16N8Na2 598.501504175 CEFUROXIME AXETIL C20H22N4O10 510.501502033 CEFUROXIME SODIUM C16H15N4Na 446.400201664 CELASTROL C29H38O4 450.601503678 CELECOXIB C17H14F3N3O 381.401502231 CELLOBIOSE (D[+]) C12H22O11 342.301504003 CENTAUREIN C24H26O13 522.501502028 CEPHALEXIN C16H17N3O4 347.401502050 CEPHALORIDINE C19H17N3O4 415.501500836 CEPHALOSPORIN C SODIUM C16H20N3Na 437.401500826 CEPHALOTAXINE C18H21NO4 315.401500166 CEPHALOTHIN SODIUM C16H15N2Na 418.401500167 CEPHAPIRIN SODIUM C17H16N3Na 445.501500168 CEPHRADINE SODIUM C16H19N3O4 349.401503200 CETRIMONIUM BROMIDE C19H42BrN 364.501500169 CETYLPYRIDINIUM CHLORIDE C21H38ClN 340.001503815 CEVADINE C32H49NO9 591.700310016 CHAULMOOGRIC ACID C18H32O2 280.500310017 CHAULMOOGRIC ACID, ETHYL ESTER C20H36O2 308.501500824 CHELIDONINE (+) C20H19NO5 353.401500837 CHENODIOL C24H40O4 392.601500171 CHLORAMBUCIL C14H19Cl2NO 304.201500173 CHLORAMPHENICOL HEMISUCCINATE C15H16Cl2N2 423.201500174 CHLORAMPHENICOL C11H12Cl2N2 323.101504212 CHLORANIL C6Cl4O2 245.900330076 CHLORDANE C10H8Cl8 411.801504211 CHLORGUANIDE HYDROCHLORIDE C11H17Cl2N5 290.201500177 CHLORHEXIDINE C22H32Cl4N1 578.402300062 CHLORMEZANONE C11H12ClNO3 273.701503341 CHLOROACETOXYQUINOLINE C11H8ClNO2 221.601500178 CHLOROCRESOL C7H7ClO 142.600210800 CHLOROGENIC ACID C16H18O9 354.301500179 CHLOROQUINE DIPHOSPHATE C18H32ClN3O 515.901500180 CHLOROTHIAZIDE C7H6ClN3O4S 295.701500181 CHLOROTRIANISENE C23H21ClO3 380.901503202 CHLOROXINE C9H5Cl2NO 214.101500182 CHLOROXYLENOL C8H9ClO 156.601500184 CHLORPROMAZINE C17H19ClN2S 318.901500185 CHLORPROPAMIDE C10H13ClN2O 276.700330051 CHLORPROPHAM C10H12ClNO2 213.701503203 CHLORPROTHIXENE HYDROCHLORIDE C18H19Cl2NS 352.300330058 CHLORPYRIFOS C9H11Cl3NO3 350.601500187 CHLORTHALIDONE C14H11ClN2O 338.801500188 CHLORZOXAZONE C7H4ClNO2 169.601500856 CHOL-11-ENIC ACID C24H36O3 372.601500838 CHOLECALCIFEROL C27H44O 384.701500851 CHOLEST-4,6-DIEN-3-ONE C27H42O 382.601500849 CHOLEST-5-EN-3-ONE C27H44O 384.701500847 CHOLESTEROL C27H46O 386.701500840 CHOLIC ACID C24H40O5 408.601500904 CHOLIC ACID, METHYL ESTER C25H42O5 422.6

Page 11

Page 22: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01503428 CHOLINE CHLORIDE C5H14ClNO 139.601400391 CHROMOCARB C10H6O4 190.201504059 CHRYSANTHELLIN A C58H94O25 1191.400310019 CHRYSANTHEMIC ACID, ETHYL ESTER C10H16O2 168.200300566 CHRYSANTHEMYL ALCOHOL C10H18O 154.300300556 CHRYSAROBIN C15H12O3 240.301500739 CHRYSIN DIMETHYL ETHER C17H14O4 282.301500709 CHRYSIN C15H10O4 254.200300545 CHRYSOPHANOL C15H10O4 254.200100010 CHUKRASIN C42H56O16 816.900100615 CHUKRASIN METHYL ETHER C43H58O16 830.900210205 CIANIDANOL C15H14O6 290.301500189 CICLOPIROX OLAMINE C14H24N2O3 268.401500684 CIMETIDINE C10H16N6S 252.301500839 CINCHONIDINE C19H22N2O 294.401500841 CINCHONINE C19H22N2O 294.401500294 CINEOLE C10H18O 154.301503204 CINNARAZINE C26H28N2 368.501500190 CINOXACIN C12H10N2O5 262.201503614 CIPROFLOXACIN C17H18FN3O3 331.301502107 CISPLATIN H6Cl2N2Pt 300.101504172 CITALOPRAM C20H21FN2O 324.401503205 CITIOLONE C6H9NO2S 159.200210186 CITRININ C13H14O5 250.301800168 CITROMYCETIN C14H10O7 290.201500707 CITROPTEN C11H10O4 206.201500855 CITRULLINE C6H13N3O3 175.201503991 CLEBOPRIDE MALEATE C24H28ClN3O 490.001500191 CLEMASTINE C25H30ClNO5 460.001503917 CLENBUTEROL HYDROCHLORIDE C12H19Cl3N2 313.701500192 CLIDINIUM BROMIDE C22H26BrNO3 432.401500193 CLINDAMYCIN HYDROCHLORIDE C18H34Cl2N2 461.501503918 CLOBETASOL PROPIONATE C25H32ClFO5 467.001503429 CLOFIBRATE C12H15ClO3 242.701500195 CLOFIBRIC ACID C10H11ClO3 214.701503206 CLOFOCTOL C21H26Cl2O 365.301500196 CLOMIPHENE CITRATE C32H36ClNO8 598.102300061 CLOMIPRAMINE HYDROCHLORIDE C19H24Cl2N2 351.301500198 CLONIDINE HYDROCHLORIDE C9H10Cl3N3 266.601503919 CLOPAMIDE C14H20ClN3O 345.901503920 CLOPERASTINE HYDROCHLORIDE C20H25Cl2NO 366.301503710 CLOPIDOGREL C16H16ClNO2 321.801500200 CLOTRIMAZOLE C22H17ClN2 344.800300133 CLOVANEDIOL DIACETATE C19H30O4 322.401500201 CLOXACILLIN SODIUM C19H17ClN3N 457.901500202 CLOXYQUIN C9H6ClNO 179.601500685 CLOZAPINE C18H19ClN4 326.801500844 COBALAMINE C73H105CoN1 1582.701504013 COENZYME Q10 C59H90O4 863.401800067 COLCHICEINE C21H23NO6 385.401500205 COLCHICINE C22H25NO6 399.401503804 COLEOFORSIN C22H34O7 410.5

Page 12

Page 23: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500206 COLISTIMETHATE SODIUM C57H103N16N 1735.801601000 COMPACTIN C23H34O5 390.501503990 CONESSINE C24H40N2 356.601503992 CONIFERYL ALCOHOL C9H10O3 166.201503993 CONIINE C8H17N 127.201503994 CONVALLATOXIN C29H42O9 534.701500861 CORALYNE CHLORIDE C22H22ClNO4 399.901500207 CORTISONE ACETATE C23H30O6 402.501701028 CORTISONE C21H28O5 360.501500876 CORYNANTHINE C21H26N2O3 354.501504037 COSMOSIIN HEXAACETATE C33H32O16 684.600350024 COSMOSIIN C21H20O10 432.400100595 COTARNINE CHLORIDE C12H12ClNO3 253.701500208 COTININE FUMARATE C14H16N2O5 292.300210591 COTOGENIN 3'-METHYL ETHER C17H18O6 318.301504000 COTOIN C14H12O4 244.200210568 COUMARINIC ACID METHYL ETHER C10H10O3 178.200330012 COUMOPHOS C14H16ClO5P 362.800300037 CRASSIN ACETATE C22H32O5 376.501600300 CREATININE C4H7N3O 113.101500209 CRESOL C7H8O 108.101401414 CRESOPYRINE C10H10O4 194.200100525 CRINAMINE C17H19NO4 301.301500210 CROMOLYN SODIUM C23H14Na2O1 512.301601010 CURCUMIN C21H20O6 368.401500211 CYCLIZINE HYDROCHLORIDE C18H23ClN2 302.901503207 CYCLOBENZAPRINE HYDROCHLORIDE C20H22ClN 311.901502085 CYCLOCREATINE C5H9N3O2 143.101502112 CYCLOHEXIMIDE C15H23NO4 281.401502128 CYCLOLEUCINE C6H11NO2 129.201502180 CYCLOLEUCYLGLYCINE C8H14N2O2 170.201500212 CYCLOPENTOLATE HYDROCHLORIDE C17H26ClNO3 327.901500213 CYCLOPHOSPHAMIDE HYDRATE C7H17Cl2N2O 279.101503912 CYCLOPIAZONIC ACID C20H20N2O3 336.401500215 CYCLOSERINE C3H6N2O2 102.101502202 CYCLOSPORIN A C62H111N11O 1202.601503263 CYCLOTHIAZIDE C14H16ClN3O 389.900100698 CYMARIN C30H44O9 548.701503606 CYPROMETHIN C22H19Cl2NO 416.301500216 CYPROTERONE ACETATE C24H29ClO4 416.901503921 CYPROTERONE C22H27ClO3 374.901503821 CYSTAMINE DIHYDROCHLORIDE C4H14Cl2N2S 225.201500217 CYTARABINE C9H13N3O5 243.201503431 CYTIDINE C9H13N3O5 243.201504027 CYTISINE C11H14N2O 190.201502182 d[-Arg-2]KYOTORPHAN ACETATE C17H27N5O6 397.401500218 DACARBAZINE C6H10N6O 182.200330025 DACTHAL C10H6Cl4O4 332.000200789 DAIDZEIN C15H10O4 254.200201281 DALBERGIONE C15H12O2 224.300201450 DALBERGIONE, 4-METHOXY-4'-HYDROXY C16H14O4 270.301500220 DANAZOL C22H27NO2 337.5

Page 13

Page 24: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01503209 DANTROLENE SODIUM C14H9N4NaO 336.200211468 DANTRON C14H8O4 240.201504141 DAPHNETIN C9H6O4 178.101500222 DAPSONE C12H12N2O2 248.300100447 DEACETOXY(7)-7-OXOKHIVORINIC ACID C27H36O10 520.600100423 DEACETOXY-7-OXISOGEDUNIN C26H30O6 438.500100047 DEACETOXY-7-OXOGEDUNIN C26H30O6 438.500100012 DEACETYLGEDUNIN C26H32O6 440.500100503 DEACETYLNOMILIN C26H34O8 474.600201538 DECAHYDROGAMBOGIC ACID C38H54O8 638.801601020 DEET C12H17NO 191.301500224 DEFEROXAMINE MESYLATE C26H52N6O11 656.800201138 DEGUELIN C23H22O6 394.400307043 DEHYDRO(11,12)URSOLIC ACID LACTONE C30H46O3 454.700307050 DEHYDROABIETAMIDE C20H29NO 299.500201136 DEHYDRODEOXYSAPPANONE B DIMETHYL ETHER C18H16O5 312.300201484 DEHYDRODIHYDROROTENONE C23H22O6 394.400100582 DEHYDROEPIANDROSTERONE C19H28O2 288.400201154 DEHYDROROTENONE C23H20O6 392.401504205 DELTALINE C24H37NO7 451.601500226 DEMECLOCYCLINE HYDROCHLORIDE C21H22Cl2N2 501.300100218 DEOXODEOXYDIHYDROGEDUNIN C28H38O5 454.601502238 DEOXYADENOSINE C10H13N5O3 251.200100016 DEOXYANDIROBIN C27H32O6 452.600100194 DEOXYANDIROBIN LACTONE C26H32O6 440.500100566 DEOXYCHOLIC ACID C24H40O4 392.600100432 DEOXYGEDUNIN C28H34O6 466.600100199 DEOXYGEDUNOL ACETATE C30H38O7 510.601502110 DEOXYGUANOSINE C10H13N5O4 267.200100139 DEOXYKHIVORIN C32H42O9 570.701503997 DEOXYRHAPONTIN C21H24O8 404.400200484 DEOXYSAPPANONE B 7,3'-DIMETHYL ETHER C18H18O5 314.300201331 DEOXYSAPPANONE B TRIMETHYL ETHER C19H20O5 328.401503127 DEQUALINIUM CHLORIDE C30H40Cl2N4 527.600201650 DERRUBONE C21H18O6 366.401401406 DERRUSNIN C19H16O7 356.300100650 DESACETYL(7)KHIVORINIC ACID, METHYL ESTER C28H40O10 536.600100475 DESFURANYL-17-OXOKHIVORIN C28H38O9 518.601500227 DESIPRAMINE HYDROCHLORIDE C18H23ClN2 302.902300192 DESMETHYLDIHYDROCAPSAICIN C17H27NO3 293.400300029 DESOXYCORTICOSTERONE ACETATE C23H32O4 372.501500231 DEXAMETHASONE ACETATE C24H31FO6 434.501500232 DEXAMETHASONE SODIUM PHOSPHATE C22H28FNa2O 516.401500230 DEXAMETHASONE C22H29FO5 392.501900001 DEXTROAMPHETAMINE C9H13N 135.201500233 DEXTROMETHORPHAN HYDROBROMIDE C18H26BrNO 352.301502010 DIACERIN C19H12O8 368.300211118 DIACETYLDIDEISOVALERYL-RHODOMYRTOXIN C18H16O7 344.300330017 DIAZINON C12H21N2O3 304.401503998 DIAZIQUONE C18H22N2O6 362.402300206 DIAZOXIDE C8H7ClN2O2S 230.701503114 DIBEKACIN C18H37N5O8 451.5

Page 14

Page 25: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500235 DIBENZOTHIOPHENE C12H8S 184.301500236 DIBUCAINE HYDROCHLORIDE C20H30ClN3O 379.900330086 DIBUTYL PHTHALATE C16H22O4 278.400330032 DICAMBA C8H6Cl2O3 221.000330036 DICHLOBENIL C7H3Cl2N 172.000330072 DICHLORODIPHENYLDICHLOROETHYLENE C14H8Cl4 318.000330070 DICHLORODIPHENYLTRICHLOROETHANE C14H9Cl5 354.501500626 DICHLOROPHENE C13H10Cl2O2 269.101501213 DICHLORPHENAMIDE C6H6Cl2N2O4 305.200330018 DICHLORVOS C4H7Cl2O4P 221.001500237 DICLOFENAC SODIUM C14H10Cl2NN 318.101500238 DICLOXACILLIN SODIUM C19H16Cl2N3 492.300100541 DICTAMNINE C12H9NO2 199.201500239 DICUMAROL C19H12O6 336.301500240 DICYCLOMINE HYDROCHLORIDE C19H36ClNO2 346.000300600 DIDEACETYL(1,3)-7-DESACETOXY-7-OXO-DEOXYKHIVORINIC C23H32O8 436.500330081 DIELDRIN C12H8Cl6O 380.901500241 DIENESTROL C18H18O2 266.301500242 DIETHYLCARBAMAZINE CITRATE C16H29N3O8 391.401500244 DIETHYLSTILBESTROL C18H20O2 268.401504118 DIFFRATIC ACID C20H22O7 374.401503299 DIFLUCORTOLONE PIVALATE C27H36F2O5 478.601500245 DIFLUNISAL C13H8F2O3 250.200300423 DIFUCOL HEXAMETHYL ETHER C18H22O6 334.400100325 DIGITONIN C56H92O29 1229.300212166 DIGITOXIGENIN ACETATE C25H36O5 416.601500246 DIGITOXIN C41H64O13 765.000100688 DIGOXIGENIN C23H34O5 390.501500247 DIGOXIN C41H64O14 781.000100458 DIHYDRO-7-DESACETYLDEOXYGEDUNIN C26H34O5 426.600211231 DIHYDRO-alpha-TOXICAROL METHYL ETHER C24H26O7 426.501504143 DIHYDROARTEMISININ C15H24O5 284.401504038 DIHYDROATRANORIN C19H20O8 376.400211531 DIHYDRO-beta-TUBAIC ACID C13H16O4 236.300307055 DIHYDROCARYOPHYLLEN-5-ONE C15H24O 220.401504082 DIHYDROCELASTROL C29H40O4 452.600380004 DIHYDROCELASTRYL DIACETATE C32H42O6 522.700203012 DIHYDRODEHYDROEROSONE C20H16O6 352.300100434 DIHYDRODEOXYGEDUNIN C28H36O6 468.601500248 DIHYDROERGOTAMINE MESYLATE C34H41N5O8 679.800100465 DIHYDROFISSINOLIDE C29H38O8 514.600300263 DIHYDROFORMONONETIN METHYL ETHER C17H16O4 284.300201524 DIHYDROGAMBOGIC ACID C38H46O8 630.800100655 DIHYDROGEDUNIC ACID, METHYL ESTER C26H36O8 476.600100361 DIHYDROGEDUNIN ETHANEDITHIOKETAL C30H40O6S2 560.800100024 DIHYDROGEDUNIN C28H36O7 484.600100489 DIHYDROGEDUNINIC ACID, METHYL ESTER C26H36O8 476.601504104 DIHYDROJASMONIC ACID C12H20O3 212.300240449 DIHYDROLANOSTEROL C30H52O 428.701401403 DIHYDROMETHYLROBUSTONE C22H20O6 380.400210203 DIHYDROMUNDULETONE C25H28O6 424.500210201 DIHYDROMUNDULONE C26H28O6 436.5

Page 15

Page 26: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00100543 DIHYDRO-OBLIQUIN C14H14O4 246.300100719 DIHYDROPTAEROXYLIN C15H16O4 260.301504084 DIHYDROROBINETIN C15H12O7 304.300201449 DIHYDROROTENONE C23H24O6 396.401504161 DIHYDROSAMIDIN C21H24O7 388.400100531 DIHYDROSPATHELIACHROMENE C15H16O4 260.301500249 DIHYDROSTREPTOMYCIN SULFATE C21H43N7O16 681.700100652 DIHYDROXY(3alpha,12alpha)PREGNAN-20-ONE C21H34O3 334.502300214 DILTIAZEM HYDROCHLORIDE C22H27ClN2O 451.001500251 DIMENHYDRINATE C24H28ClN5O 470.001500252 DIMERCAPTOPROPANOL C3H8OS2 124.201500253 DIMETHADIONE C5H7NO3 129.100330020 DIMETHOATE C5H12NO3PS 229.301503974 DIMETHYL 4,4-o-PHENYLENE-BIS(3-THIOPHANATE) C12H14N4O4 342.400210567 DIMETHYLCAFFEIC ACID C11H12O4 208.201503036 DINITOLMIDE C8H7N3O5 225.200100318 DIOSGENIN C27H42O3 414.601504068 DIOSMETIN C16H12O6 300.301503219 DIOSMIN C28H32O15 608.601500255 DIOXYBENZONE C14H12O4 244.201500256 DIPHENHYDRAMINE HYDROCHLORIDE C17H22ClNO 291.801500258 DIPHENYLPYRALINE HYDROCHLORIDE C19H24ClNO 317.900211126 DIPHENYLUREA C13H12N2O 212.301504209 DIPLOSALSALATE C16H12O6 300.301502183 DIPROTIN A C17H31N3O4 341.501500259 DIPYRIDAMOLE C24H40N8O4 504.601503032 DIPYROCETYL C11H10O6 238.201503298 DIPYRONE C13H16N3Na 333.301504144 DIRITHROMYCIN C42H78N2O14 835.101500261 DISOPYRAMIDE PHOSPHATE C21H32N3O5 437.501500262 DISULFIRAM C10H20N2S4 296.500330014 DISULFOTON C8H19O2PS3 274.400330030 DIURON C9H10Cl2N2O 233.100310008 DJENKOLIC ACID C7H14N2O4S 254.301503212 DOBUTAMINE HYDROCHLORIDE C18H24ClNO3 337.802300212 DOMPERIDONE C22H24ClN5O 425.901500263 DOPAMINE HYDROCHLORIDE C8H12ClNO2 189.601500264 DOXEPIN HYDROCHLORIDE C19H22ClNO 315.801500266 DOXYCYCLINE HYDROCHLORIDE C22H25ClN2O 480.901500267 DOXYLAMINE SUCCINATE C21H28N2O5 388.501503391 D-PHENYLALANINE C9H11NO2 165.201500999 DROFENINE HYDROCHLORIDE C20H32ClNO2 353.901501002 DROPERIDOL C22H22FN3O2 379.401501004 DROPROPIZINE C13H20N2O2 236.300201177 DUARTIN (-) C18H20O6 332.400201364 DUARTIN, DIMETHYL ETHER C20H24O6 360.401600906 DURLETTONE C21H20O4 336.401500268 DYCLONINE HYDROCHLORIDE C18H28ClNO2 325.901500269 DYPHYLLINE C10H14N4O4 254.201501188 EBSELEN C13H9NOSe 274.201502239 EBURNAMONINE C19H22N2O 294.401501128 E-CAPSAICIN C18H27NO3 305.4

Page 16

Page 27: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01800123 ECHINOCYSTIC ACID C30H48O4 472.701501185 ECONAZOLE NITRATE C18H16Cl3N3 444.701503214 EDOXUDINE C11H16N2O5 256.302300219 EDROPHONIUM CHLORIDE C10H16ClNO 201.700330073 ELDRIN C12H8Cl6O 380.901502245 ELLAGIC ACID C14H6O8 302.201504074 EMBELIN C17H26O4 294.401500272 EMETINE C29H42Cl2N2 553.601504060 EMODIC ACID C15H8O7 300.201500898 EMODIN C15H10O5 270.201501214 ENALAPRIL MALEATE C24H32N2O9 492.500330083 ENDOSULFAN C9H6Cl6O3S 406.901503215 ENOXACIN C15H17FN4O3 320.301500990 ENOXOLONE C30H46O4 470.701503721 ENROFLOXACIN C19H22FN3O3 359.400100517 ENTANDROPHRAGMIN C43H56O17 844.901500273 EPHEDRINE (1R,2S) HYDROCHLORIDE C10H16ClNO 201.700300058 EPI(13)TORULOSOL C20H34O2 306.500210211 EPIAFZELECHIN TRIMETHYL ETHER C18H20O5 316.400310009 EPIANDROSTERONE C19H30O2 290.401601032 EPICATECHIN 3,5-DIGALLATE C29H22O14 594.500210238 EPICATECHIN MONOGALLATE C22H18O10 442.400210206 EPICATECHIN C15H14O6 290.300210503 EPICATECHIN, TETRAMETHYL ETHER C19H22O6 346.401504056 EPICOPROSTEROL C27H48O 388.700211477 EPIGALLOCATCHIN GALLATE METHYL ETHER C30H34O11 570.600201513 EPIGALLOCATECHIN 3,5-DIGALLATE C29H22O15 610.501601040 EPIGALLOCATECHIN OCTAMETHYL ETHER C30H34O11 570.600205113 EPIGALLOCATECHIN C15H14O7 306.300210239 EPIGALLOCATECHIN-3-MONOGALLATE C22H18O11 458.400241071 EPITHEAFLAVIC ACID C21H16O10 428.400100368 EPOXY(1,2alpha)-7-DEACETOXY-7-OXO- C26H30O6 438.500100464 EPOXY(2,3alpha)-7-DEACETOXY-7-OXODIHYDROISOGEDUNIN C26H30O7 454.500100173 EPOXYGEDUNIN C28H34O8 498.601500275 EQUILIN C18H20O2 268.400211590 EQUOL DIMETHYL ETHER C17H18O3 270.301500276 ERGOCALCIFEROL C28H44O 396.701500277 ERGONOVINE MALEATE C23H27N3O6 441.500200744 ERGOSTEROL ACETATE C32H50O2 466.800200743 ERGOSTEROL C28H44O 396.701501193 ERYSOLIN C6H11NO2S2 193.301500279 ERYTHROMYCIN ETHYLSUCCINATE C43H75NO16 862.101501176 ERYTHROMYCIN PROPIONATE LAURYL SULFATE C52H97NO18 1056.401500280 ERYTHROMYCIN C37H67NO13 733.901500899 ESCULETIN C9H6O4 178.101500753 ESERINE C15H21N3O2 275.401501184 ESTRADIOL ACETATE C20H26O3 314.401501182 ESTRADIOL BENZOATE C25H28O3 376.501500283 ESTRADIOL CYPIONATE C26H36O3 396.601501180 ESTRADIOL DIACETATE C22H28O4 356.501501183 ESTRADIOL METHYL ETHER C19H26O2 286.401501179 ESTRADIOL PROPIONATE C21H28O3 328.5

Page 17

Page 28: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500284 ESTRADIOL VALERATE C23H32O3 356.501500282 ESTRADIOL C18H24O2 272.401501192 ESTRADIOL-3-SULFATE, SODIUM SALT C18H23NaO5 374.401501177 ESTRIOL BENZOATE C25H28O4 392.501501191 ESTRIOL BENZYL ETHER C25H30O3 378.501501178 ESTRIOL METHYL ETHER C19H26O3 302.401500285 ESTRIOL C18H24O3 288.401501181 ESTRONE ACETATE C20H24O3 312.401503676 ESTRONE HEMISUCCINATE C22H26O5 370.401500286 ESTRONE C18H22O2 270.401503412 ETANIDAZOLE C7H10N4O4 214.201500287 ETHACRYNIC ACID C13H12Cl2O4 303.101500288 ETHAMBUTOL DIHYDROCHLORIDE C10H26Cl2N2 277.201501000 ETHAVERINE HYDROCHLORIDE C24H30ClNO4 432.001500291 ETHINYL ESTRADIOL C20H24O2 296.400330011 ETHION C9H22O4P2S4 384.501500292 ETHIONAMIDE C8H10N2S 166.201503221 ETHISTERONE C21H28O2 312.500330065 ETHOPROP C8H19O2PS2 242.301500293 ETHOPROPAZINE HYDROCHLORIDE C19H25ClN2S 348.901502196 ETHOSUXIMIDE C7H11NO2 141.201500998 ETHOXYQUIN C14H19NO 217.302300078 ETHYL 1-BENZYL-3-HYDROXY- 2-OXO[5H]PYRROLE-4- C14H15NO4 261.301504088 ETHYLNOREPINEPHRINE HYDROCHLORIDE C10H16ClNO3 233.700270002 ETIOCHOLANOLONE C19H30O2 290.401501005 ETODOLAC C17H21NO3 287.401500903 ETOPOSIDE C29H32O13 588.601500295 EUCATROPINE HYDROCHLORIDE C17H26ClNO3 327.900210752 EUDESMIC ACID C10H12O5 212.200200447 EUGENITOL C11H10O4 206.201500296 EUGENOL C10H12O2 164.200300157 EUGENYL BENZOATE C17H16O3 268.300300007 EUPARIN C13H12O3 216.201500731 EUPATORIN C18H16O7 344.300300061 EUPATORIOCHROMENE C13H14O3 218.300100583 EUPHOL ACETATE C32H52O2 468.800201697 EUPHOL C30H50O 426.700201343 EVERNIC ACID C17H16O7 332.300201727 EVERNINIC ACID C8H8O5 184.101504020 EVOXINE C18H21NO6 347.401503403 EXALAMIDE C13H19NO2 221.301501003 FAMOTIDINE C8H15N7O2S 337.401501022 FARNESOL C15H26O 222.401504164 FELAMIDIN C21H18O5 350.400305025 FENAMISAL C13H11NO3 229.201501016 FENBENDAZOLE C15H13N3O2 299.401501008 FENBUFEN C16H14O3 254.301504223 FENBUTYRAMIDE C10H13NO 163.201501026 FENDILINE HYDROCHLORIDE C23H26ClN 351.901900025 FENFLURAMINE C12H17ClF3N 267.701501010 FENOFIBRATE C20H21ClO4 360.801501011 FENOPROFEN C15H14O3 242.3

Page 18

Page 29: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01501007 FENOTEROL HYDROBROMIDE C17H22BrNO4 384.301501021 FENSPIRIDE HYDROCHLORIDE C15H21ClN2O 296.800330064 FENTHION C10H15O3PS2 278.301501017 FERULIC ACID C10H10O4 194.201504179 FEXOFENADINE C32H39NO4 501.701503216 FILIPIN C35H58O11 654.801503222 FIPEXIDE HYDROCHLORIDE C20H22Cl2N2 425.301502247 FISETIN C15H10O6 286.200100031 FISSINOLIDE C29H36O8 512.600200343 FLAVANONE C15H12O2 224.301500629 FLOPROPIONE C9H10O4 182.201503059 FLOXURIDINE C9H11FN2O5 246.201503975 FLUCONAZOLE C13H12F2N6O 306.301500299 FLUDROCORTISONE ACETATE C23H31FO6 422.500300025 FLUFENAMIC ACID C14H10F3NO2 281.201500994 FLUFENAZINE HYDROCHLORIDE C22H28Cl2F3 510.501500992 FLUMEQUINE C14H12FNO3 261.301501196 FLUMETHASONE C22H28F2O5 410.501500300 FLUMETHAZONE PIVALATE C27H36F2O6 494.601500993 FLUNARIZINE HYDROCHLORIDE C26H28Cl2F2 477.401501187 FLUNISOLIDE C24H31FO6 434.501500302 FLUOCINOLONE ACETONIDE C24H30F2O6 452.501500303 FLUOCINONIDE C26H32F2O7 494.501500304 FLUOROMETHOLONE C22H29FO4 376.501500305 FLUOROURACIL C4H3FN2O2 130.101504173 FLUOXETINE HYDROCHLORIDE C17H19ClF3N 345.801501175 FLURANDRENOLIDE C24H33FO6 436.501500308 FLURBIPROFEN C15H13FO2 244.301500995 FLUTAMIDE C11H11F3N2O 276.201503945 FLUTRIMAZOLE C22H16F2N2 346.401502020 FOLIC ACID C19H19N7O6 441.401504116 FORMESTANE C20H28O2 300.400102007 FORMONONETN C16H12O4 268.301502019 FOSCARNET CNa3O5P 192.001502012 FOSFOSAL C7H7O6P 218.101503944 FOSINOPRIL SODIUM C30H45NNaO 585.701502039 FOSPHOMYCIN C3H5CaO4P 176.101504069 FRAXETIN C10H8O5 208.200100572 FRAXIDIN METHYL ETHER C12H12O5 236.201800170 FREQUENTIN C14H20O4 252.300100551 FRIEDELIN C30H50O 426.701504053 FUCOSTANOL C29H52O 416.701500309 FURAZOLIDONE C8H7N3O5 225.201501195 FUREGRELATE SODIUM C15H10NNaO 275.201500310 FUROSEMIDE C12H11ClN2O 330.701500311 FUSIDIC ACID C31H48O6 516.701503648 GABOXADOL HYDROCHLORIDE C6H9ClN2O2 176.601501202 GALANTHAMINE HYDROBROMIDE C17H22BrNO3 368.301500312 GALLAMINE C30H60I3N3O 891.500210369 GALLIC ACID C7H6O5 170.100200007 GAMBOGIC ACID C38H44O8 628.800201522 GAMBOGIC ACID AMIDE C38H45NO7 627.8

Page 19

Page 30: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00201536 GAMBOGIC ACID MORPHOLINE ADDUCT C42H53NO9 715.900200031 GAMBOGINIC ACID, METHYL ESTER C39H47ClO8 679.301500678 gamma-AMINOBUTYRIC ACID C4H9NO2 103.100200035 GANGLEOIDIN C18H14Cl2O7 413.200300222 GANGLEOIDIN ACETATE C20H16Cl2O8 455.300201539 GARCINOLIC ACID C38H46O9 646.802300090 GBR 12909 C28H34Cl2F2 523.500100032 GEDUNIN C28H34O7 482.600100375 GEDUNOL C28H36O7 484.601500313 GEMFIBROZIL C15H22O3 250.300210296 GENISTEIN C15H10O5 270.200201355 GENISTEIN, 8-METHYL C16H12O5 284.301503661 GENISTIN C21H20O10 432.401500724 GENKWANIN C16H12O5 284.301500314 GENTAMICIN SULFATE C21H45N5O11 575.701500315 GENTIAN VIOLET C25H30ClN3 408.000211307 GENTISIC ACID C7H6O4 154.100300021 GIBBERELLIC ACID C19H22O6 346.400200431 GINKGETIN TETRAETHYL ETHER C40H38O10 678.700200436 GINKGETIN C32H22O10 566.501500984 GINKGOLIDE A C20H24O11 440.401504102 GINSENOSIDE B1 C54H92O24 1125.301504093 GINSENOSIDE G1 C42H72O14 801.001504113 GINSENOSIDE Rd C48H82O19 963.200100584 GITOXIGENIN DIACETATE C27H38O7 474.600100687 GITOXIGENIN C23H34O5 390.501500986 GITOXIN C41H64O14 781.001500996 GLAFENINE C19H17ClN2O 372.802300229 GLIBENCLAMIDE C23H28ClN3O 494.001504145 GLICLAZIDE C15H21N3O3 323.401503989 GLUCITOL-4-GUCOPYANOSIDE C12H24O11 344.301503092 GLUCONOLACTONE C6H10O6 178.101500316 GLUCOSAMINE HYDROCHLORIDE C6H14ClNO5 215.600310298 GLUCOSAMINIC ACID C6H13NO6 195.201500987 GLUTAMINE C5H10N2O3 146.101502248 GLUTATHIONE C10H17N3O6 307.301500991 GLYCYRRHIZIC ACID C41H60O16 808.900330047 GLYPHOSATE C3H8NO5P 169.101504019 GOSSYPOL C30H30O8 518.601502099 GOSSYPOL-ACETIC ACID COMPLEX C32H34O10 578.601500319 GRAMICIDIN C60H92N12O1 1141.500100454 GRANDIFOLIOLENONE C32H50O6 530.800201662 GRAYANOTOXIN I C22H36O7 412.500200243 GRISEOFULVIC ACID C16H15ClO6 338.700102070 GRISEOFULVIN ANALOG B C17H13Cl3O5 403.600102073 GRISEOFULVIN ANALOG C C16H11Cl3O5 389.600102078 GRISEOFULVIN ANALOG D C15H9Cl3O5 375.600240782 GRISEOFULVIN ANALOG E C14H6Cl4O5 396.000240882 GRISEOFULVIN ANALOG C15H10Cl2O5 341.100200046 GRISEOFULVIN C17H17ClO6 352.801502249 GUAIAZULENE C15H18 198.301500321 GUAIFENESIN C10H14O4 198.2

Page 20

Page 31: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500322 GUANABENZ ACETATE C10H12Cl2N4 291.101500323 GUANETHIDINE SULFATE C10H24N4O4 296.401500761 GUANIDINE CARBONATE C2H7N3O3 121.100200061 GYROPHORIC ACID C24H20O10 468.400205071 HAEMATOMMIC ACID, ETHYL ESTER C11H12O5 224.200240944 HAEMATOXYLIN PENTAACETATE C26H24O12 528.500200010 HAEMATOXYLIN C16H14O6 302.300201133 HAEMATOXYLONE, TETRAMETHYL- C20H20O7 372.401500324 HALAZONE C7H5Cl2NO4S 270.101503237 HALCINONIDE C24H32ClFO5 455.001500325 HALOPERIDOL C21H23ClFNO 375.901500326 HALOPROGIN C9H4Cl3IO 361.401500864 HARMALINE C13H14N2O 214.301500865 HARMALOL HYDROCHLORIDE C12H13ClN2O 236.701500866 HARMANE C12H10N2 182.201500867 HARMINE C13H12N2O 212.301502237 HARMOL HYDROCHLORIDE C12H11ClN2O 234.700100034 HAVANENSIN TRIACETATE C32H44O8 556.700100099 HAVANENSIN C26H38O5 430.600100310 HECOGENIN ACETATE C29H44O5 472.701500760 HECOGENIN C27H42O4 430.601504018 HEDERACOSIDE C C59H96O26 1221.401504016 HEDERAGENIN C30H48O4 472.700310010 HELENINE C15H20O2 232.301502253 HEMATEIN C16H12O6 300.300330078 HEPTACHLOR C10H5Cl7 373.301503218 HEPTAMINOL HYDROCHLORIDE C8H20ClNO 181.700210874 HERNIARIN C10H8O3 176.200310012 HESPERETIN C16H14O6 302.300310011 HESPERIDIN C28H34O15 610.601500327 HETACILLIN POTASSIUM C19H22KN3O 427.600100529 HETEROPEUCENIN, METHYL ETHER C16H18O4 274.300100035 HEUDELOTTIN C C39H54O11 698.901500328 HEXACHLOROPHENE C13H6Cl6O2 406.901503297 HEXAMETHONIUM BROMIDE C12H30Br2N2 362.201500632 HEXESTROL C18H22O2 270.401500633 HEXETIDINE C21H45N3 339.601500330 HEXYLRESORCINOL C12H18O2 194.301504115 HIERACIN C15H10O7 302.200211152 HIPTAGIN C18H24N4O18 584.401500331 HISTAMINE DIHYDROCHLORIDE C5H11Cl2N3 184.101500332 HOMATROPINE BROMIDE C16H22BrNO3 356.301500333 HOMATROPINE METHYLBROMIDE C17H24BrNO3 370.301503806 HOMIDIUM BROMIDE C21H20BrN3 394.300100743 HOMOPTEROCARPIN C17H16O4 284.300100088 HUMILIN A C29H36O9 528.601501210 HUMULENE(alpha) C15H24 204.401503239 HYCANTHONE C20H24N2O2 356.501500334 HYDRALAZINE HYDROCHLORIDE C8H9ClN4 196.600310006 HYDRASTININE HYDROCHLORIDE C11H14ClNO3 243.701500335 HYDROCHLOROTHIAZIDE C7H8ClN3O4S 297.701500338 HYDROCORTISONE ACETATE C23H32O6 404.5

Page 21

Page 32: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01503273 HYDROCORTISONE BUTYRATE C25H36O6 432.601500339 HYDROCORTISONE HEMISUCCINATE C25H34O8 462.501500340 HYDROCORTISONE SODIUM PHOSPHATE C21H29Na2O8 486.400300024 HYDROCORTISONE C21H30O5 362.501501014 HYDROCOTARNINE C12H15NO3 221.300201081 HYDROCOTOIN C15H14O4 258.301500341 HYDROFLUMETHIAZIDE C8H8F3N3O4 331.301500657 HYDROQUINIDINE C20H26N2O2 326.400100280 HYDROXY(19)TOTAROL C20H30O2 302.500100305 HYDROXY(3beta)ISOALLOSPIROST-9(11)-ENE C27H42O3 414.601503978 HYDROXYCHLOROQUINE C18H26ClN3O 335.901500343 HYDROXYPROGESTERONE CAPROATE C27H40O4 428.602300100 HYDROXYTACRINE MALEATE C17H18N2O5 330.301500344 HYDROXYUREA CH4N2O2 76.100300540 HYMECROMONE METHYL ETHER C11H10O3 190.201500346 HYOSCYAMINE C17H23NO3 289.400200489 HYPOPROTOCETRARIC ACID C18H16O7 344.300310023 HYPOXANTHINE C5H4N4O 136.101500345 HYYDROXYZINE PAMOATE C44H43ClN2O 763.301500347 IBUPROFEN C13H18O2 206.300102018 ICHTHYNONE C23H20O7 408.401504208 IMIDACLOPRID C9H10ClN5O2 255.701502073 IMIDAZOL-4-YLACETIC ACID HYDROCHLORIDE C5H7ClN2O2 162.601500348 IMIPRAMINE HYDROCHLORIDE C19H25ClN2 316.900102076 IMPERATORIN C16H14O4 270.301500349 INDAPAMIDE C16H16ClN3O 365.801502082 INDOLE-2-CARBOXYLIC ACID C9H7NO2 161.201500350 INDOMETHACIN C19H16ClNO4 357.801500351 INDOPROFEN C17H15NO3 281.300310024 INOSINE C10H12N4O5 268.201504117 INOSITOL C6H12O6 180.201500772 IODIPAMIDE C12H11I3N2O 627.901500353 IODOQUINOL C9H5I2NO 397.001503923 IOPANIC ACID C11H12I3NO2 570.901400010 IPRAFLAVONE C18H16O3 280.301500354 IPRATROPIUM BROMIDE C20H30BrNO3 412.401500634 IPRONIAZID SULFATE C9H15N3O5S 277.300200759 IRETOL C7H8O4 156.100200793 IRIDIN C24H26O13 522.500200873 IRIGENIN TRIMETHYL ETHER C21H22O8 402.400200763 IRIGENIN, 7-BENZYL ETHER C25H22O8 450.400201182 IRIGENOL C15H10O8 318.200211012 IRIGINOL HEXAACEATATE C27H22O14 570.500300032 ISOBERGAPTENE C12H8O4 216.202300204 ISOBUTYLMETHYLXANTHINE C10H14N4O2 222.201500860 ISOCORYDINE (+) C20H23NO4 341.401401404 ISODERRUBONE C21H18O6 366.400200449 ISOEUGENITOL C11H10O4 206.200205077 ISOFERULIC ACID C10H10O4 194.200100195 ISOGEDUNIN C28H34O7 482.600200433 ISOGINKGETIN C32H22O10 566.501502129 ISOGUVACINE HYDROCHLORIDE C6H10ClNO2 163.6

Page 22

Page 33: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00300117 ISOKOBUSONE C14H22O2 222.301504200 ISOLIQUIRITIGENIN C15H12O4 256.301500355 ISONIAZID C6H7N3O 137.101504166 ISOOSAJIN C25H24O5 404.500300340 ISOPILOCARPINE NITRATE C11H17N3O5 271.300300012 ISOPIMPINELLIN C13H10O5 246.201500356 ISOPROPAMIDE IODIDE C23H33IN2O 480.401500357 ISOPROTERENOL HYDROCHLORIDE C11H18ClNO3 247.700300534 ISORESERPINE C33H40N2O9 608.700200015 ISOROTENONE C23H22O6 394.400300533 ISOSAFROLE C10H10O2 162.201500358 ISOSORBIDE DINITRATE C6H8N2O8 236.100201341 ISOTECTORIGENIN TRIMETHYL ETHER C19H18O6 342.401504095 ISOTHIPENDYL HYDROCHLORIDE C16H20ClN3S 321.901502013 ISOTRETINON C20H28O2 300.400240819 ISOVIOLASTYRENE C17H18O3 270.300300536 ISOXANTHOPTERIN C6H5N5O2 179.101503242 ISOXICAM C14H13N3O5 335.301500359 ISOXSUPRINE HYDROCHLORIDE C18H24ClNO3 337.800300038 JUGLONE C10H6O3 174.202300228 KAINIC ACID C10H15NO4 213.201500360 KANAMYCIN A SULFATE C18H38N4O15 582.601501208 KARANJIN C17H10O4 278.301504146 KATACINE C45H38O21 914.801500361 KETAMINE HYDROCHLORIDE C13H17Cl2NO 274.201500362 KETOCONAZOLE C26H28Cl2N4 531.401501215 KETOPROFEN C16H14O3 254.301503925 KETOROLAC TROMETHAMINE C19H24N2O6 376.401500668 KETOTIFEN FUMARATE C23H23NO5S 425.500100049 KHAYANTHONE C32H42O9 570.700100103 KHAYASIN C C30H38O8 526.600100050 KHAYASIN C32H42O8 554.700210866 KHELLIN C14H12O5 260.200100162 KHIVORIN C32H42O10 586.701501207 KINETIN RIBOSIDE C15H17N5O5 347.301500764 KINETIN C10H9N5O 215.200300048 KOBUSONE C14H22O2 222.301800166 KOJIC ACID C6H6O4 142.101504040 k-STROPHANTHIN beta C36H54O14 710.800240862 KUHLMANNIN C17H14O5 298.301500877 KYNURAMINE C9H12N2O 164.201500688 KYNURENIC ACID C10H7NO3 189.201500879 KYNURENINE C10H12N2O3 208.201503243 LABETALOL HYDROCHLORIDE C19H25ClN2O 364.901500363 LACTULOSE C12H22O11 342.301504024 LAGOCHILIN C20H36O5 356.501501205 LANATOSIDE C C49H76O20 985.100240470 LANOSTEROL C30H50O 426.700201696 LANOSTEROL ACETATE C32H52O2 468.801503926 LANSOPRAZOLE C16H14F3N3O 369.401501204 LAPACHOL C15H14O3 242.300310025 LARIXINIC ACID C6H6O3 126.1

Page 23

Page 34: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00300056 LARIXOL C20H34O2 306.500300057 LARIXOL ACETATE C22H36O3 348.501503244 LASALOCID SODIUM C34H53NaO8 612.801500843 LATHOSTEROL C27H46O 386.700100575 LAUDANOSINE C21H27NO4 357.501502250 LAWSONE C10H6O3 174.200200070 LECANORIC ACID C16H14O7 318.301503927 LEFUNAMIDE C12H9F3N2O2 270.200300516 LEOIDIN DIACETATE C22H18Cl2O9 497.300241150 LEOIDIN DIMETHYL ETHER C20H18Cl2O7 441.301504103 LEOIDIN MONOACETATE C20H16Cl2O8 455.300200033 LEOIDIN C18H14Cl2O7 413.201502178 LEUCINE ENKEPHALIN C28H37N5O7 555.601504149 LEUCODIN C15H18O3 246.301500874 LEUCOPTERIN C6H5N5O3 195.101500364 LEUCOVORIN CALCIUM C20H21CaN7 511.501503245 LEVAMISOLE HYDROCHLORIDE C11H13ClN2S 240.802300205 LEVODOPA C9H11NO4 197.201500365 LEVONORDEFRIN C9H13NO3 183.201500689 LIDOCAINE HYDROCHLORIDE C14H23ClN2O 270.801504029 LIGUSTILIDE C12H14O2 190.201503813 LIMOCITRIN C17H14O8 346.301501212 LINALOOL(+) C10H18O 154.301504124 LINAMARIN C10H17NO6 247.301500368 LINCOMYCIN HYDROCHLORIDE C18H35ClN2O 443.000330071 LINDANE C6H6Cl6 290.801502047 LIOTHYRONINE SODIUM C15H11I3NNa 673.001600561 LIQUIRTIGENIN DIMETHYL ETHER C17H16O4 284.301501217 LISINOPRIL C21H31N3O5 405.501500848 LITHOCHOL-11-ENIC ACID C24H38O3 374.601500906 LITHOCHOLIC ACID C24H40O3 376.601503951 LIVIDOMYCIN A C29H57N5O22 859.900300018 LOBARIC ACID C25H28O8 456.501501023 LOBELANIDINE HYDROCHLORIDE C22H29NO2 339.501500758 LOBELINE SULFATE C22H29NO6S 435.501504071 LOGANIC ACID C16H24O10 376.401504066 LOGANIN C17H26O10 390.401504158 LOMATIN C14H14O4 246.301502037 LOMEFLOXACIN HYDROCHLORIDE C17H20ClF2N 387.800203015 LONCHOCARPIC ACID ACETATE C28H30O6 462.500300567 LONCHOCARPIC ACID DIACETATE C30H32O7 504.600300228 LONCHOCARPIC ACID C26H26O6 434.501503225 LONIDAMINE C15H10Cl2N2 321.202300241 LOPERAMIDE HYDROCHLORIDE C29H34Cl2N2 513.501503712 LORATADINE C22H23ClN2O 382.901503977 LOVASTATIN C24H36O5 404.602300242 LOXAPINE SUCCINATE C22H24ClN3O 445.901504021 LUPININE C10H19NO 169.301503249 LUPITIDINE HYDROCHLORIDE C21H28ClN5O 450.000380003 LYCOPENE C40H56 536.900100279 LYCORINE C16H17NO4 287.301502241 LYSERGOL C16H18N2O 254.3

Page 24

Page 35: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01502186 LYSYL-TYROSYL-LYSINE ACETATE C23H39N5O7 497.600201654 MAACKIAIN C16H12O5 284.301400679 MACLURIN C13H10O6 262.200200107 MACLUROXANTHONE C23H22O6 394.401500372 MAFENIDE HYDROCHLORIDE C7H11ClN2O2 222.700330021 MALATHION C10H19O6PS2 330.400201466 MANDELIC ACID, METHYL ESTER C9H10O3 166.201500373 MAPROTILINE HYDROCHLORIDE C20H24ClN 313.901504163 MARMESIN ACETATE C16H16O5 288.301504162 MARMESIN C14H14O4 246.301501110 MEBENDAZOLE C16H13N3O3 295.301501117 MEBEVERINE HYDROCHLORIDE C25H36ClNO5 466.001501116 MEBHYDROLIN NAPHTHALENESULFONATE C29H28N2O6 564.701500374 MECAMYLAMINE HYDROCHLORIDE C11H22ClN 203.801500375 MECHLORETHAMINE C5H11Cl2N 156.101500376 MECLIZINE HYDROCHLORIDE C25H29Cl3N2 463.901501118 MECLOCYCLINE SULFOSALICYLATE C29H27ClN2O 695.101503226 MECLOFENOXATE HYDROCHLORIDE C12H17Cl2NO 294.201500636 MECYSTEINE HYDROCHLORIDE C4H10ClNO2S 171.600201156 MEDICARPIN C16H14O4 270.301500379 MEDROXYPROGESTERONE ACETATE C24H34O4 386.501500380 MEDRYSONE C22H32O3 344.501501103 MEFENAMIC ACID C15H15NO2 241.301501108 MEFEXAMIDE C15H25ClN2O 316.801503070 MEFLOQUINE C17H16F6N2O 378.301500690 MELATONIN C13H16N2O2 232.300300531 MELEZITOSE C18H32O16 504.401504150 MELOXICAM C14H13N3O4 351.401500382 MELPHALAN C13H18Cl2N2 305.201501121 MEMANTINE HYDROCHLORIDE C12H22ClN 215.801502254 MENADIONE C11H8O2 172.200300564 MENTHONE C10H18O 154.301800005 MENTHYL BENZOATE C17H24O2 260.401503432 MEPARTRICIN C60H88N2O19 1141.401500383 MEPENZOLATE BROMIDE C21H26BrNO3 420.401900028 MEPERIDINE HYDROCHLORIDE C15H22ClNO2 283.801501140 MEPHENESIN C10H14O3 182.201503250 MEPHENTERMINE SULFATE C11H19NO4S 261.301503709 MEPHENTOIN C12H14N2O2 218.301504148 MEPIVACAINE HYDROCHLORIDE C15H23ClN2O 282.801500637 MERBROMIN C20H8Br2HgN 750.701504226 MERCAPTAMINE HYDROCHLORIDE C2H8ClNS 113.601500387 MERCAPTOPURINE C5H4N4S 152.200100455 MEROGEDUNIN C21H28O4 344.500100686 MEROGEDUNIN, 3-DEOXO-1alpha,3alpha-DIHYDROXYDIHYDRO- C21H30O4 346.501900029 MESCALINE HYDROCHLORIDE C11H18ClNO3 247.701502014 MESNA C2H5NaO3S2 164.200211175 METACETAMOL C8H9NO2 151.200300062 METAMECONINE C10H10O4 194.201502034 METAMPICILLIN SODIUM C17H18N3Na 383.401500390 METAPROTERENOL C11H17NO3 211.301503251 METARAMINOL BITARTRATE C13H19NO8 317.3

Page 25

Page 36: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01504189 METATYRAMINE HYDROCHLORIDE C8H12ClNO 173.600300565 METERGOLINE C25H29N3O2 403.501500391 METHACHOLINE CHLORIDE C8H18ClNO2 195.701501104 METHACYCLINE HYDROCHLORIDE C22H23ClN2O 478.900330023 METHAMIDOPHOS C2H8NO2PS 141.101503229 METHAPYRILENE HYDROCHLORIDE C14H20ClN3S 297.901503252 METHAZOLAMIDE C5H8N4O3S2 236.301500394 METHENAMINE C6H12N4 140.201500395 METHICILLIN SODIUM C17H19N2Na 402.401500396 METHIMAZOLE C4H6N2S 114.201502177 METHIONYL-LEUCYLPHENYLALANINE ACETATE C22H35N3O6 469.601503637 METHIOTHEPIN MALEATE C24H28N2O4 472.601500397 METHOCARBAMOL C11H15NO5 241.200330060 METHOMYL C5H10N2O2S 162.201504100 METHOPRENE (S) C17H30O3 282.401500398 METHOTREXATE C20H22N8O5 454.401500399 METHOXAMINE HYDROCHLORIDE C11H18ClNO3 247.701500400 METHOXSALEN C12H8O4 216.201503970 METHOXYAMINE HYDROCHLORIDE CH6ClNO 83.500330077 METHOXYCHLOR C16H15Cl3O2 345.701400666 METHOXYVONE C17H14O3 266.301500401 METHSCOPOLAMINE BROMIDE C18H24BrNO4 398.300350004 METHYL ABIETATE C21H32O2 316.500200191 METHYL COCLAURINE C18H21NO3 299.400210674 METHYL GAMBOGINATE C39H47ClO7 663.300330010 METHYL PARATHIONE C8H10NO5PS 263.201401401 METHYL ROBUSTONE C22H18O6 378.401503253 METHYLBENZTHONIUM CHLORIDE C28H44ClNO2 462.100208014 METHYLCHROMONE C10H8O2 160.201500403 METHYLDOPA C10H13NO4 211.201500404 METHYLERGONOVINE MALEATE C24H29N3O6 455.500330003 METHYLMETHANE SULFONATE C2H6O3S 110.100240642 METHYLNORLICHEXANTHONE C15H12O5 272.300210072 METHYLORSELLINIC ACID, ETHYL ESTER C11H14O4 210.201503255 METHYLPREDNISOLONE HEMISUCCINATE C26H34O8 474.601503723 METHYLPREDNISOLONE SODIUM SUCCINATE C26H33NaO8 496.501500406 METHYLPREDNISOLONE C22H30O5 374.501500408 METHYLTHIOURACIL C5H6N2OS 142.200300427 METOCHALCONE C18H18O4 298.301500410 METOCLOPRAMIDE HYDROCHLORIDE C14H23Cl2N3 336.300330035 METOLACHLOR C15H22ClNO2 283.802300325 METOLAZONE C16H16ClN3O 365.801500411 METOPROLOL TARTRATE C19H31NO9 417.501500412 METRONIDAZOLE C6H9N3O3 171.200330015 MEVINPHOS C8H15O6P 238.202300296 MEXAMINE C11H15ClN2O 226.700102036 MEXICANOLIDE ENOL ETHER C28H34O7 482.600100060 MEXICANOLIDE C27H32O7 468.601503929 MEXILETINE HYDROCHLORIDE C11H18ClNO 215.702300292 MIANSERIN HYDROCHLORIDE C18H21ClN2 300.801500413 MICONAZOLE NITRATE C18H15Cl4N3 479.101503257 MIDODRINE HYDROCHLORIDE C12H19ClN2O 290.7

Page 26

Page 37: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500869 MIMOSINE C8H10N2O4 198.201501120 MINAPRINE HYDROCHLORIDE C17H24Cl2N4 371.301500414 MINOCYCLINE HYDROCHLORIDE C23H28ClN3O 493.901500415 MINOXIDIL C9H15N5O 209.300330002 MITOMYCIN C C15H18N4O5 334.300330082 MITOTANE C14H10Cl4 320.001503278 MITOXANTHRONE HYDROCHLORIDE C22H30Cl2N4 517.401503416 MIZORIBINE C9H13N3O6 259.201500673 MOLSIDOMINE C9H14N4O4 242.201504128 MOLSOFLAVONE C17H14O5 298.301502258 MONENSIN SODIUM (monensin A is shown) C37H63NaO10 690.901502252 MONOCROTALINE C16H23NO6 325.401503931 MORANTEL CITRATE C18H24N2O7 412.501502259 MORIN C15H10O7 302.201500418 MOXALACTAM DISODIUM C20H18N6Na2 564.401501211 MUCIC ACID C6H10O8 210.100201477 MUNDOSERONE C19H18O6 342.400200011 MUNDULONE C26H26O6 434.500212009 MUNDULONE BENZOATE C33H30O7 538.600307056 MUUROLLADIE-3-ONE C15H22O 218.302300088 MY-5445 C20H14ClN3 331.801500674 MYCOPHENOLIC ACID C17H20O6 320.301500870 MYOSMINE C9H10N2 146.201504065 MYRICETIN C15H10O8 318.201503638 N-(2-AMINOETHYL)-4-CHLOROBENZAMIDE C9H12Cl2N2O 235.101503633 N-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE C11H14ClF3N 266.701503642 N-(9-FLUORENYLMETHOXYCARBONYL)-L-LEUCINE C21H23NO4 353.401502155 N(g)-NITRO-L-ARGININE C6H13N5O4 219.201503999 N,N-DIMETHYLAMILORIDE C8H13Cl2N7O 294.101504215 N,N-HEXAMETHYLENEAMILORIDE C12H18ClN7O 311.801503650 NABUMETONE C15H16O2 228.301504213 N-ACETYLASPARTIC ACID C6H9NO5 175.102300147 N-ACETYLNEURAMIC ACID C11H19NO9 309.301500704 N-ACETYLPROLINE C7H11NO3 157.201500419 NADIDE C21H27N7O14 663.401503260 NADOLOL C17H27NO4 309.401500420 NAFCILLIN SODIUM C21H21N2Na 436.501503419 NAFRONYL OXALATE C26H35NO7 473.601501115 NALBUPHINE HYDROCHLORIDE C21H28ClNO4 393.900330016 NALED C4H7Br2Cl2O 380.801500756 NALIDIXIC ACID C12H12N2O3 232.201500422 NALOXONE HYDROCHLORIDE C19H22ClNO4 363.801503262 NALTREXONE HYDROCHLORIDE C20H23NO4 341.401503627 N-AMINOHEXYL-5-CHLORO-1-NAPTHALENESULFONAMIDE C16H22Cl2N2 377.302300310 N-AMINOHEXYL-5-CHLORONAPHTH-1-YLSULFONAMIDE C16H21ClN2O 340.901500424 NAPHAZOLINE HYDROCHLORIDE C14H15ClN2 246.701503801 NAPROXOL C14H16O2 216.301502035 NARASIN C43H72O11 765.001500746 NARINGENIN C15H12O5 272.301500765 NARINGIN C27H32O14 580.501502056 N-CARBOXYHEPTYLIMIDAZOLE HYDROCHLORIDE C11H19ClN2O 246.701502075 NCS-382 C13H14O3 218.3

Page 27

Page 38: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01501137 NEFOPAM C17H19NO 253.301500750 NEOHESPERIDIN DIHYDROCHALCONE C28H36O15 612.601500427 NEOMYCIN SULFATE C23H48N6O17 712.701500428 NEOSTIGMINE BROMIDE C12H19BrN2O 303.200100296 NEOTIGOGENIN ACETATE C29H46O4 458.701501136 NERIIFOLIN C30H46O8 534.701501132 NEROL C10H18O 154.301502251 NEROLIDOL C15H26O 222.401502172 N-FORMYLMETHIONYLALANINE C9H16N2O4S 248.301502173 N-FORMYLMETHIONYL-LEUCYLPHENYLALANINE C21H31N3O5 437.601502175 N-FORMYLMETHIONYLPHENYLALANINE C15H20N2O4 324.401502194 Ng-METHYL-L-ARGININE ACETATE C9H20N4O4 248.302300137 N-HYDROXYMETHYLNICOTINAMIDE C7H8N2O2 152.201500430 NIACIN C6H5NO2 123.101501135 NICARDIPINE HYDROCHLORIDE C26H30ClN3O 516.001501133 NICERGOLINE C24H26BrN3O 484.401503265 NICOLSAMIDE C13H8Cl2N2O 327.102300259 NICOTINE DITARTRATE C18H26N2O12 462.401500431 NIFEDIPINE C17H18N2O6 346.301503230 NIFENAZONE C17H16N4O2 308.301502015 NIFLUMIC ACID C13H9F3N2O2 282.201503913 NIGERICIN SODIUM C40H67NaO11 747.000100090 NILOTICIN C30H48O3 456.701504152 NILUTAMIDE C12H10F3N3O 317.201503231 NIMESULIDE C13H12N2O5 308.301503600 NIMODIPINE C21H26N2O7 418.501504151 NIMUSTINE C9H13ClN6O2 272.702300345 NIPECOTIC ACID C6H11NO2 129.201503609 NITREDIPINE C18H20N2O6 360.401500433 NITROFURANTOIN C8H6N4O5 238.201500434 NITROFURAZONE C6H6N4O4 198.101500435 NITROMIDE C7H5N3O5 211.102300220 N-METHYL(-)EPHEDRINE C11H17NO 179.301600964 N-METHYLANTHANILIC ACID C8H9NO2 151.201503636 N-METHYL-D-ASPARTIC ACID C5H9NO4 147.101503266 NOCODAZOLE C14H11N3O3 301.301503267 NOMIFENSIN MALEATE C20H22N2O4 354.400201227 NONIC ACID C9H16O4 188.201504187 NONOXYNOL 9 C33H60O10 616.801502262 NOPALINE C11H20N4O6 304.301504153 NORCANTHARIDIN C8H8O4 168.200210397 NORDEFRIN HYDROCHLORIDE C9H14ClNO3 219.701502206 NORDIHYDROGUARETIC ACID C18H22O4 302.401500939 NORELEAGNINE C11H12N2 172.201500436 NOREPINEPHRINE C8H11NO3 169.201500438 NORETHINDRONE ACETATE C22H28O3 340.501500437 NORETHINDRONE C20H26O2 298.401500439 NORETHYNODREL C20H26O2 298.401500440 NORFLOXACIN C16H18FN3O3 319.301500441 NORGESTREL C21H28O2 312.501500871 NORHARMANE C11H8N2 168.200200488 NORSTICTIC ACID PENTAACETATE C28H24O15 600.5

Page 28

Page 39: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00201716 NORSTICTIC ACID C18H12O9 372.301500442 NORTRIPTYLINE C19H21N 263.401500443 NOSCAPINE HYDROCHLORIDE C22H24ClNO7 449.901500444 NOVOBIOCIN SODIUM C31H35N2Na 634.601502171 N-tBOC-NORLEUCYLEUCYLPHENYLALANINE C26H41N3O6 491.601500445 NYLIDRIN HYDROCHLORIDE C19H26ClNO2 335.900100202 NYMANIA 2 C31H44O8 544.701500446 NYSTATIN C47H75NO17 926.100100066 OBACUNOL C26H32O7 456.500100540 OBLIQUIN C14H12O4 244.201500639 OCTOPAMINE HYDROCHLORIDE C8H12ClNO2 189.600100093 ODORATONE C30H48O4 472.701502044 OFLOXACIN C18H20FN3O4 361.400240871 OLEANANOIC ACID ACETATE C32H52O4 500.801500675 OLEANDOMYCIN PHOSPHATE C35H64NO16 785.901501209 OLEANDRIN C32H48O10 592.700100550 OLEANOIC ACID C30H48O3 456.700102058 OLEANOLIC ACID ACETATE C32H50O4 498.801601001 OLIGOMYCIN (A shown) C45H74O11 791.101504177 OMEPRAZOLE C17H19N3O3 345.401503711 ORBIFLOXACIN C19H20F3N3O 395.401503369 ORNITHINE SULFATE C5H14N2O6S 230.201500447 ORPHENADRINE CITRATE C24H31NO8 461.500300001 ORSELLINIC ACID C8H8O4 168.200200002 ORSELLINIC ACID, ETHYL ESTER C10H12O4 196.200231017 ORTHOTHYMOTINIC ACID C11H14O3 194.200200109 OSAJAXANTHONE C18H14O5 310.300201595 OSAJIN C25H24O5 404.501504165 OSTHOL C15H16O3 244.301500676 OUABAIN C29H44O12 584.701500448 OXACILLIN SODIUM C19H18N3Na 423.400330019 OXDEMETONMETHYL C6H15O4PS2 246.301503279 OXETHAZINE C28H41N3O3 467.701500450 OXIDOPAMINE HYDROCHLORIDE C8H12ClNO3 205.601502030 OXOLINIC ACID C13H11NO5 261.201500846 OXOLITHOCHOLIC ACID C24H38O4 390.600100563 OXONITINE C33H43NO12 645.702300260 OXOTREMORINE METHIODIDE C11H19IN2O 322.201503626 OXOTREMORINE SESQUIFUMARATE C16H22N2O5 322.401503373 OXYBENDAZOLE C12H15N3O3 249.301500451 OXYBENZONE C14H12O3 228.201500453 OXYMETAZOLINE HYDROCHLORIDE C16H25ClN2O 296.801500455 OXYPHENBUTAZONE C19H20N2O3 324.401503932 OXYPHENCYCLIMINE HYDROCHLORIDE C20H29ClN2O 380.901500456 OXYQUINOLINE C9H7NO 145.201500457 OXYTETRACYCLINE C22H25ClN2O 496.900201602 PACHYRRHIZIN C19H12O6 336.300201657 PACHYRRHIZONE C20H14O7 366.301503908 PACLITAXEL C47H51NO14 853.901500872 PALMATINE CHLORIDE C21H22ClNO4 387.901500459 PAPAVERINE HYDROCHLORIDE C20H22ClNO4 375.901500460 PARACHLOROPHENOL C6H5ClO 128.6

Page 29

Page 40: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00330055 PARADICHLOROBENZENE C6H4Cl2 147.001503223 PARAROSANILINE PAMOATE C42H33N3O6 675.702300170 PARAXANTHINE C7H8N4O2 180.201500462 PARGYLINE HYDROCHLORIDE C11H14ClN 195.701503228 PAROMOMYCIN SULFATE C23H47N5O18 713.701504085 PAROXETINE HYDROCHLORIDE C19H21ClFNO 365.801503640 PARTHENOLIDE C15H20O3 248.301503381 PASINIAZIDE C13H14N4O4 290.301503904 PATULIN C7H6O4 154.101502162 p-CHLOROPHENYLALANINE C9H10ClNO2 199.600200115 PECTOLINARIN C29H34O15 622.600300553 PELLETIERINE HYDROCHLORIDE C8H16ClNO 177.701503383 PEMPIDINE TARTRATE C14H27NO6 305.401500464 PENICILLAMINE C5H11NO2S 149.201500465 PENICILLIN G POTASSIUM C16H17KN2O 372.501500467 PENICILLIN V POTASSIUM C16H17KN2O 388.500330056 PENTACHLOROPHENOL C6HCl5O 266.301500641 PENTAMIDINE ISETHIONATE C23H36N4O10 592.702300347 PENTETRAZOLE C6H10N4 138.201900006 PENTOBARBITAL C11H18N2O3 226.301503933 PENTOLINIUM DITARTRATE C23H42N2O12 538.601503611 PENTOXIFYLLINE C13H18N4O3 278.301503269 PERGOLIDE MESYLATE C20H30N2O3 410.601503227 PERHEXILLINE MALEATE C23H39NO4 393.601503936 PERICIAZINE C21H23N3OS 365.501502101 PERILLIC ACID (-) C10H14O2 166.200100588 PERIPLOCYMARIN C30H46O8 534.701503934 PERPHENAZINE C21H26ClN3O 404.000202130 PERSEITOL C7H16O7 212.200240437 PERSITOL HEPTAACETATE C21H30O14 506.501501113 PERUVOSIDE C30H44O9 548.701504168 PEUCEDANIN C15H14O4 258.300100528 PEUCENIN C15H16O4 260.301502114 p-FLUOROPHENYLALANINE C9H10FNO2 183.201500472 PHENACEMIDE C9H10N2O2 178.201500642 PHENACETIN C10H13NO2 179.201500473 PHENAZOPYRIDINE HYDROCHLORIDE C11H12ClN5 249.701500476 PHENELZINE SULFATE C8H14N2O4S 234.301500643 PHENETHICILLIN POTASSIUM C17H19KN2O 402.501500477 PHENINDIONE C15H10O2 222.201500478 PHENIRAMINE MALEATE C20H24N2O4 356.401900032 PHENOBARBITAL C12H12N2O3 232.201500480 PHENOLPHTHALEIN C20H14O4 318.301504098 PHENOTHRIN C23H26O3 350.502300176 PHENOXYBENZAMINE HYDROCHLORIDE C18H23Cl2NO 340.301500691 PHENTOLAMINE HYDROCHLORIDE C17H20ClN3O 317.800210031 PHENYLACETOHYDROXAMIC ACID C8H9NO2 151.202300073 PHENYLBIGUANIDE C8H11N5 177.201500482 PHENYLBUTAZONE C19H20N2O2 308.400306001 PHENYLBUTYRIC ACID C10H12O2 164.201500483 PHENYLEPHRINE HYDROCHLORIDE C9H14ClNO2 203.701500644 PHENYLMERCURIC ACETATE C8H8HgO2 336.7

Page 30

Page 41: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500484 PHENYLPROPANOLAMINE HYDROCHLORIDE C9H14ClNO 187.701500485 PHENYTOIN SODIUM C15H11N2Na 274.300300554 PHLORETIN C15H14O5 274.300300547 PHLORIDZIN C21H24O10 436.400330024 PHORATE C7H17O2PS3 260.400330004 PHORBOL MYRISTATE ACETATE C36H56O8 616.800330022 PHOSALONE C12H15ClNO4 367.801502021 PHTHALYLSULFATHIAZOLE C17H13N3O5 403.401504070 PHYSCION C16H12O5 284.301500486 PHYSOSTIGMINE SALICYLATE C22H27N3O5 413.502300067 PHYSOSTIGMINE SULFATE C15H23N3O6 373.400310021 PHYTOL C19H38O 282.501500827 PICEID C21H24O8 404.400100346 PICROTIN C15H18O7 310.301501107 PICROTOXININ C15H16O6 292.301500487 PILOCARPINE NITRATE C11H17N3O5 271.301501114 PIMETHIXENE MALEATE C23H23NO4S 409.501501134 PIMOZIDE C28H29F2N3O 461.600300013 PIMPINELLIN C13H10O5 246.202300270 PINACIDIL C13H19N5 245.301500488 PINDOLOL C14H20N2O2 248.301504154 PINOCEMBRIN C15H12O4 256.300201066 PINOSYLVIN C14H12O2 212.301502024 PIPEMIDIC ACID C14H17N5O3 303.301503053 PIPENZOLATE BROMIDE C22H28BrNO3 434.401500489 PIPERACILLIN SODIUM C23H26N5Na 539.501500490 PIPERAZINE C4H10N2 86.101502197 PIPERIDOLATE HYDROCHLORIDE C21H26ClNO2 359.901500873 PIPERINE C17H19NO3 285.301503393 PIPOBROMAN C10H16Br2N2 356.101502195 PIRACETAM C6H10N2O2 142.201504188 PIRENPERONE C23H24FN3O2 393.501501138 PIRENZEPINE HYDROCHLORIDE C19H23Cl2N5 424.301502045 PIROMIDIC ACID C14H16N4O3 288.301500491 PIROXICAM C15H13N3O4 331.400200427 PISCIDIC ACID C11H12O7 256.202300332 PODOPHYLLOTOXIN C22H22O8 414.400100268 PODOTOTARIN ACETATE C44H62O4 655.000100286 PODOTOTARIN C40H58O2 570.901500492 POLYMYXIN B SULFATE C56H100N16O 1301.600201580 POMIFERIN C25H24O6 420.501500113 POTASSIUM p-AMINOBENZOATE C7H6KNO2 175.201503632 PRACTOLOL C14H22N2O3 266.301502043 PRALIDOXIME MESYLATE C8H12N2O4S 232.301504202 PRAMIPEXOLE DIHYDROCHLORIDE C10H19Cl2N3 284.301501139 PRAMOXINE HYDROCHLORIDE C17H28ClNO3 329.901500494 PRAZIQUANTEL C19H24N2O2 312.401500495 PRAZOSIN HYDROCHLORIDE C19H22ClN5O 419.901500497 PREDNISOLONE ACETATE C23H30O6 402.501500496 PREDNISOLONE C21H28O5 360.501500499 PREDNISONE C21H26O5 358.401503677 PREGNENOLONE SULFATE, SODIUM SALT C21H31NaO5 418.5

Page 31

Page 42: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500645 PREGNENOLONE C21H32O2 316.500100101 PRENYLETIN C14H14O4 246.301503077 PRIDINOL METHANESULFONATE C21H29NO4S 391.500100068 PRIEURIANIN C38H50O16 762.801503270 PRILOCAINE HYDROCHLORIDE C13H21ClN2O 256.801500500 PRIMAQUINE DIPHOSPHATE C15H27N3O9 455.301500501 PRIMIDONE C12H14N2O2 218.301502084 PROADIFEN HYDROCHLORIDE C23H32ClNO2 390.001500502 PROBENECID C13H19NO4S 285.401501109 PROBUCOL C31H48O2S2 516.901500503 PROCAINAMIDE HYDROCHLORIDE C13H22ClN3O 271.801500504 PROCAINE HYDROCHLORIDE C13H21ClN2O 272.801503232 PROCATEROL HYDROCHLORIDE C16H23ClN2O 326.801500505 PROCHLORPERAZINE EDISYLATE C22H30ClN3O 564.101500507 PROCYCLIDINE HYDROCHLORIDE C19H30ClNO 323.901500508 PROGESTERONE C21H30O2 314.501501119 PROGLUMIDE C18H26N2O4 334.401500509 PROMAZINE HYDROCHLORIDE C17H21ClN2S 320.901500510 PROMETHAZINE HYDROCHLORIDE C17H21ClN2S 320.900330034 PROMETON C10H19N5O 225.300330037 PROMETRYN C10H19N5S 241.401503628 PRONETHALOL HYDROCHLORIDE C15H20ClNO 265.800330052 PROPACHLOR C11H14ClNO 211.701503935 PROPAFENONE HYDROCHLORIDE C21H28ClNO3 377.900330027 PROPANIL C9H9Cl2NO 218.101500511 PROPANTHELINE BROMIDE C23H30BrNO3 448.400330067 PROPARGITE C19H26O4S 350.500330026 PROPAZINE C9H16ClN5 229.701503079 PROPENTOFYLLINE C15H22N4O3 306.401500512 PROPIOMAZINE MALEATE C24H28N2O5 456.600330066 PROPOXUR C11H15NO3 209.201500514 PROPRANOLOL HYDROCHLORIDE C16H22ClNO2 295.801500515 PROPYLTHIOURACIL C7H10N2OS 170.201501111 PROTOPORPHYRIN IX C34H34N4O4 562.701500909 PROTOVERATRINE A C41H63NO14 794.001500938 PROTOVERATRINE B C41H63NO15 810.001500726 PRUNETIN C16H12O5 284.300240914 PSEUDO-ANISATIN C15H22O6 298.301500516 PSEUDOEPHEDRINE HYDROCHLORIDE C10H16ClNO 201.700200040 PSOROMIC ACID C18H14O8 358.301504106 PSOROMIC ACID HYDRATE C18H16O9 376.300100513 PTAEROXYLIN C15H14O4 258.302300330 PTERIN-6-CARBOXYLIC ACID C7H5N5O3 207.101504160 PTERYXIN C21H22O7 386.400400011 PUNCTAPORIN B C15H24O3 252.401501105 PUROMYCIN HYDROCHLORIDE C22H31Cl2N7 544.400210505 PURPUROGALLIN C11H8O5 220.200210564 PURPUROGALLIN TETRAACETATE C19H16O9 388.300240889 PURPUROGALLIN TETRAMETHYL ETHER C15H16O5 276.300240826 PURPUROGALLIN-4-CARBOXYLIC ACID C12H8O7 264.201503952 PUTRESCINE DIHYDROCHLORIDE C4H14Cl2N2 161.101500517 PYRANTEL PAMOATE C34H30N2O6 594.7

Page 32

Page 43: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500518 PYRAZINAMIDE C5H5N3O 123.100330068 PYRETHRINS C20H26O3 314.401503240 PYRIDOSTIGMINE BROMIDE C9H13BrN2O2 261.101500519 PYRILAMINE MALEATE C21H27N3O5 401.501500520 PYRIMETHAMINE C12H13ClN4 248.701500260 PYRITHIONE ZINC C10H10N2O2 319.701503085 PYRITHYLDIONE C9H13NO2 167.200210515 PYROGALLIN C11H8O4 204.201500521 PYRVINIUM PAMOATE C49H43N3O6 769.900310028 QUASSIN C22H28O6 388.501502261 QUEBRACHITOL C7H14O6 194.200300538 QUERCETIN TETRAMETHYL(5,7,3',4') ETHER C19H18O7 358.401500672 QUERCETIN C15H10O7 302.201500752 QUERCITRIN C21H20O11 448.401500522 QUINACRINE HYDROCHLORIDE C23H32Cl3N3 472.901500759 QUINALIZARIN C14H8O6 272.200210837 QUINAMIDE ISOPROPYLIDENE C10H17NO5 231.301503076 QUINAPRIL HYDROCHLORIDE C25H31ClN2O 475.000310018 QUINIC ACID C7H12O6 192.201500523 QUINIDINE GLUCONATE C26H36N2O9 520.600310050 QUININE ETHYL CARBONATE C23H28N2O4 396.501500524 QUININE SULFATE C20H26N2O6 422.501502102 QUINOLINIC ACID C7H5NO4 167.101503420 QUIPAZINE MALEATE C17H19N3O4 329.401500525 RACEPHEDRINE HYDROCHLORIDE C10H16ClNO 201.701503822 RAMIPHENAZONE C14H20ClN3O 281.801501151 RANITIDINE C13H22N4O3 314.401500778 RATHYRONINE C15H12I3NO4 651.001503639 RAUWOLSCINE HYDROCHLORIDE C21H27ClN2O 390.901500751 RESCINNAMINE C35H42N2O9 634.701500526 RESERPINE C33H40N2O9 608.701503500 RESORCINOL MONOACETATE C8H8O3 152.201500527 RESORCINOL C6H6O2 110.101504044 RESVERATROL 4'-METHYL ETHER C15H14O3 242.301502223 RESVERATROL C14H12O3 228.201501203 RETINOL C20H30O 286.501503051 RETINYL ACETATE C22H32O2 328.501503604 RETINYL PALMITATE C36H60O2 524.900200255 RETUSOQUINONE C11H12O 160.200310031 RHAMNETIN C16H12O7 316.301502243 RHAPONTIN C21H24O9 420.401504176 RHETSININE C19H17N3O2 319.401504134 RHIZONIC ACID C10H12O4 196.200310030 RHODINYL ACETATE C12H22O2 198.301504119 RHODOMYRTOXIN B C24H28O7 428.501504034 RHODOMYRTOXIN C24H28O7 428.501504075 RHOIFOLIN C27H30O14 578.501503938 RIBAVIRIN C8H12N4O5 244.201503939 RIBOSTAMYCIN SULFATE C17H36N4O14 552.601500529 RIFAMPIN C43H58N4O12 823.001503421 RITANSERIN C27H25F2N3O 477.601501149 RITODRINE HYDROCHLORIDE C17H22ClNO3 323.8

Page 33

Page 44: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

02300283 Ro-411049 HYDROCHLORIDE C12H13ClFN3 301.801500732 ROBINETIN TRIMETHYL ETHER C18H16O7 344.300310032 ROBININ C33H40O19 740.700240660 ROBUSTIC ACID METHYL ETHER C23H22O6 394.400240673 ROBUSTIC ACID C22H20O6 380.400210454 ROBUSTONE C21H16O6 364.400200428 ROCCELLIC ACID C17H32O4 300.400100308 ROCKOGENIN C27H44O4 432.601501154 RONIDAZOLE C6H8N4O4 200.201502094 ROSMARINIC ACID C18H16O8 360.301500762 ROSOLIC ACID C19H14O3 290.300200013 ROTENONE C23H22O6 394.400200851 ROTENONIC ACID C23H24O6 396.400240590 ROTENONIC ACID, METHYL ETHER C24H26O6 410.501500530 ROXARSONE C6H6AsNO6 263.001503276 ROXITHROMYCIN C41H76N2O15 837.100200009 RUTILANTIN C30H35NO11 585.600300607 RUTOSIDE C27H32O16 612.500330053 S,S,S,-TRIBUTYLPHOSPHOROTRITHIOATE C12H27OPS3 314.501501171 SACCHARIN C7H5NO3S 183.201503620 SAFROLE C10H10O2 162.200100577 SAFROLGLYCOL C10H12O4 196.201502255 SALICIN C13H18O7 286.301500531 SALICYL ALCOHOL C7H8O2 124.101500532 SALICYLAMIDE C7H7NO2 137.100300618 SALICYLANILIDE C13H11NO2 213.201503602 SALINOMYCIN, SODIUM C42H69NaO11 773.000200331 SALSALATE C14H10O5 258.201504022 SALSOLIDINE C12H17NO2 207.301504025 SALSOLINE C11H15NO2 193.200310035 SANGUINARINE SULFATE C20H15NO8S 429.400300542 SANTONIN C15H18O3 246.301504017 SAPINDOSIDE A C41H66O12 751.001600365 SAPPANONE A TRIMETHYL ETHER C19H18O5 326.400100682 SARMENTOGENIN C23H34O5 390.500100568 SARMENTOSIDE B C34H48O13 664.800211566 SCANDENIN DIACETATE C30H30O8 518.600300348 SCANDENIN C26H26O6 434.501500183 S-CHLORPHENIRAMINE MALEATE C20H23ClN2O 390.901500534 SCOPOLAMINE HYDROBROMIDE C17H22BrNO4 384.301502242 SCOPOLETIN C10H8O4 192.200310038 SCOPOLINE C8H13NO2 155.201503720 SELAMECTIN C43H64O10 741.001504159 SELINIDIN C19H20O5 328.401503422 SEMUSTINE C10H18ClN3O 247.700300052 SENECRASSIDIOL 6-ACETATE C17H28O3 280.401504078 SENNOSIDE A C42H38O20 862.801504080 SENNOSIDE B C42H38O20 862.800201581 SERICETIN C25H24O5 404.500201584 SERICETIN DIACETATE C29H28O7 488.501502256 SHIKIMIC ACID C7H10O5 174.201504099 SILDENAFIL C22H30N6O4 474.6

Page 34

Page 45: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

00330028 SIMAZINE C7H12ClN5 201.701500536 SISOMICIN SULFATE C19H39N5O11 545.600107023 SITOSTERYL ACETATE C31H52O2 456.800100298 SMILAGENIN ACETATE C29H46O4 458.700107013 SMILAGENIN C27H44O3 416.600107015 SMILAGENONE C27H42O3 414.601502060 SNAP (S-NITROSO-N-ACETYLPENICILLAMINE) C7H12N2O4S 220.201503902 SODIUM beta-NICOTINAMIDE ADENINE DINUCLEOTIDE C21H27N7Na 765.401500225 SODIUM DEHYDROCHOLATE C24H33NaO5 424.500330009 SODIUM FLUOROACETATE C2H2FNaO2 100.001500377 SODIUM MECLOFENAMATE C14H10Cl2NN 318.101500116 SODIUM p-AMINOSALICYLATE C7H6NNaO3 175.101500533 SODIUM SALICYLATE C7H5NaO3 160.100100537 SOLASODINE C27H43NO2 413.600300003 SOLIDAGENONE C20H28O3 316.401503630 SPAGLUMIC ACID C11H16N2O8 304.301502189 SPARC C20H36N8O5 468.600300548 SPARTEINE SULFATE C15H28N2O4 332.501500538 SPECTINOMYCIN HYDROCHLORIDE C14H26Cl2N2 405.301503940 SPERMIDINE TRIHYDROCHLORIDE C7H22Cl3N3 254.600300005 SPHONDIN C12H8O4 216.201501152 SPIPERONE C23H26FN3O2 395.501503423 SPIRAMYCIN C43H74N2O14 843.101500539 SPIRONOLACTONE C24H32O4S 416.601502078 STATIL C17H12BrFN2 391.201503629 STEAROYLCARNITINE CHLORIDE C25H50ClNO4 464.100300006 STICTIC ACID C19H14O9 386.301504051 STIGMASTEROL C29H48O 412.701500541 STREPTOMYCIN SULFATE C21H41N7O16 679.701500543 STREPTOZOSIN C8H15N3O7 265.200330079 STROBANE C10H10Cl8 413.800100292 STROPHANTHIDIN ACETATE C25H34O7 446.500100731 STROPHANTHIDIN SEMICARBAZIDE C24H35N3O6 461.600100291 STROPHANTHIDIN C23H32O6 404.500100749 STROPHANTHIDINIC ACID LACTONE ACETATE C25H32O7 444.501500651 STRYCHNINE C21H22N2O2 334.401502098 SUCCINYLACETONE C7H10O4 158.201502025 SUCCINYLSULFATHIAZOLE C13H13N3O5 355.401501148 SULCONAZOLE NITRATE C18H16Cl3N3 460.801500544 SULFABENZAMIDE C13H12N2O3 276.301500545 SULFACETAMIDE C8H10N2O3S 214.201501142 SULFACHLORPYRIDAZINE C10H9ClN4O2 284.701500546 SULFADIAZINE C10H10N4O2 250.301501144 SULFADIMETHOXINE C12H14N4O4 310.301501146 SULFAGUANIDINE C7H10N4O2S 214.201500547 SULFAMERAZINE C11H12N4O2 264.301501155 SULFAMETER C11H12N4O3 280.301500548 SULFAMETHAZINE C12H14N4O2 278.301500549 SULFAMETHIZOLE C9H10N4O2S 270.301500550 SULFAMETHOXAZOLE C10H11N3O3 253.301501156 SULFAMETHOXYPYRIDAZINE C11H12N4O3 280.301501147 SULFAMONOMETHOXINE C11H12N4O3 280.3

Page 35

Page 46: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500646 SULFANILAMIDE C6H8N2O2S 172.201503339 SULFANITRAN C14H13N3O5 335.301501143 SULFAPHENAZOLE C15H14N4O2 314.401500551 SULFAPYRIDINE C11H11N3O2 249.301501145 SULFAQUINOXALINE SODIUM C14H11N4Na 322.301500552 SULFASALAZINE C18H14N4O5 398.401500553 SULFATHIAZOLE C9H9N3O2S2 255.301500554 SULFINPYRAZONE C23H20N2O3 404.501500555 SULFISOXAZOLE C11H13N3O3 267.301500556 SULINDAC C20H17FO3S 356.401501159 SULMAZOLE C14H13N3O2 287.301501153 SULOCTIDIL C20H35NOS 337.601501150 SULPIRIDE C15H23N3O4 341.400200822 SUMATROL ACETATE C25H24O8 452.500300399 SUMATROL C23H22O7 410.401500779 SUPROFEN METHYL ESTER C15H14O3S 274.301501161 SUPROFEN C14H12O3S 260.301502032 SURAMIN C51H34N6Na6 1429.201501157 SUXIBUZONE C24H26N2O6 438.500100076 SWIETENINE C32H40O9 568.700100094 SWIETENOLIDE-3-ACETATE C29H36O9 528.601401301 SYRINGIC ACID C9H10O5 198.201502123 t-4-AMINOCROTONIC ACID C4H7NO2 101.101500557 TAMOXIFEN CITRATE C32H37NO8 563.701504105 TANNIC ACID C76H52O46 1701.200330031 TEBUTHIURON C9H16N4OS 228.300201328 TECTORIGENIN C16H12O6 300.300330062 TEMEPHOS C16H20O6P2S 466.501504094 TENIPOSIDE C32H32O13S 656.701503142 TENOXICAM C13H11N3O4 337.401500558 TERBUTALINE HEMISULFATE C12H21NO7S 323.401503708 TERFENADINE C32H41NO2 471.700300034 TESTOSTERONE PROPIONATE C22H32O3 344.500307023 TESTOSTERONE C19H28O2 288.401500564 TETRACAINE HYDROCHLORIDE C15H25ClN2O 300.801504101 TETRACHLOROISOPHTHALONITRILE C8Cl4N2 265.901500566 TETRACYCLINE HYDROCHLORIDE C22H25ClN2O 480.900201540 TETRAHYDROGAMBOGIC ACID C38H48O8 632.801504178 TETRAHYDROPALMATINE C21H25NO4 355.401600480 TETRAHYDROSAPPANONE A TRIMETHYL ETHER C19H22O5 330.400240485 TETRAHYDROTRIMETHYLHISPIDIN C16H20O5 292.301500567 TETRAHYDROZOLINE HYDROCHLORIDE C13H17ClN2 236.701504185 TETRANDRINE C38H42N2O6 622.801503330 TETROQUINONE C6H4O6 172.101503607 THALIDOMIDE C13H10N2O4 258.200211709 THEAFLAVANIN C20H16O8 384.300240788 THEAFLAVIC ACID C21H16O10 428.400201515 THEAFLAVIN DIGALLATE C43H32O20 868.700210242 THEAFLAVIN MONOGALLATES C36H28O16 716.600200111 THEAFLAVIN C29H24O12 564.501500649 THEOBROMINE C7H8N4O2 180.201500568 THEOPHYLLINE C7H8N4O2 180.2

Page 36

Page 47: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01504023 THERMOPSINE PERCHLORATE C15H25ClN2O 348.801500570 THIABENDAZOLE C10H7N3S 201.301503136 THIAMPHENICOL C12H15Cl2NO 356.201900002 THIAMYLAL SODIUM C12H17N2Na 276.301500572 THIMEROSAL C9H9HgNaO2 404.801503941 THIOCTIC ACID C8H14O2S2 206.301503325 THIODIGLYCOL C4H10O2S 122.201500573 THIOGUANINE C5H5N5S 167.201500575 THIORIDAZINE HYDROCHLORIDE C21H27ClN2S 407.001503324 THIOTEPA C6H12N3PS 189.201500576 THIOTHIXENE C23H29N3O2 443.601503094 THIOXOLONE C7H4O3S 168.201503322 THIRAM C6H12N2S4 240.401503135 THONZYLAMINE HYDROCHLORIDE C16H23ClN4O 322.801502022 THYMOPENTIN C30H49N9O9 679.800310299 THYMOQUINONE C10H12O2 164.201500774 THYROXINE C15H11I4NO4 776.901503086 TIAPRIDE HYDROCHLORIDE C15H25ClN2O 364.900100315 TIGOGENIN C27H44O3 416.602300009 TILORONE C25H34N2O3 410.601500578 TIMOLOL MALEATE C17H28N4O7 432.501503320 TIMONACIC C4H7NO2S 133.201502127 TINIDAZOLE C8H13N3O4S 247.301500579 TOBRAMYCIN C18H37N5O9 467.501501174 TODRALAZINE HYDROCHLORIDE C11H13ClN4O 268.701501201 TOLAZAMIDE C14H21N3O3 311.401500580 TOLAZOLINE HYDROCHLORIDE C10H13ClN2 196.701500581 TOLBUTAMIDE C12H18N2O3 270.401501198 TOLFENAMIC ACID C14H12ClNO2 261.701500582 TOLMETIN SODIUM C15H14NNaO 279.301500583 TOLNAFTATE C19H17NOS 307.401501194 TOLPERISONE HYDROCHLORIDE C16H24ClNO 281.800100301 TOMATIDINE C27H45NO2 415.701504079 TOMATINE C47H79NO21 994.100100271 TOTARALOLAL C20H28O2 300.400100267 TOTAROL ACETATE C22H32O2 328.500100275 TOTAROL METHYL ETHER C21H32O 300.500100287 TOTAROL C20H30O 286.500100612 TOTAROL-19-CARBOXYLIC ACID, METHYL ESTER C21H30O3 330.500330075 TOXAPHENE C10H10Cl8 413.800203010 TOXICAROL(alpha) C23H22O7 410.401502026 TRANEXAMIC ACID C8H15NO2 157.201500584 TRANYLCYPROMINE SULFATE C9H13NO4S 231.301503121 TRAZODONE HYDROCHLORIDE C19H23Cl2N5 408.301502016 TRETINON C20H28O2 300.401500585 TRIACETIN C9H14O6 218.201504041 TRIACETYLRESVERATROL C20H18O6 354.400330054 TRIALLATE C10H16Cl3NO 304.701500587 TRIAMCINOLONE ACETONIDE C24H31FO6 434.501503099 TRIAMCINOLONE BENETONIDE C35H42FNO8 623.701500588 TRIAMCINOLONE DIACETATE C25H31FO8 478.501500586 TRIAMCINOLONE C21H27FO6 394.4

Page 37

Page 48: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

01500589 TRIAMTERENE C12H11N7 253.300100098 TRICHILENONE C25H32O4 396.501500590 TRICHLORMETHIAZIDE C8H8Cl3N3O4 380.700300563 TRICHLORMETHINE C6H13Cl4N 241.000100576 TRIDESACETOXYKHIVORIN C26H36O7 460.600100478 TRIDESACETYLDEOXYKHIVORIN C26H36O6 444.601500591 TRIFLUOPERAZINE HYDROCHLORIDE C21H26Cl2F3 480.401503118 TRIFLUPROMAZINE HYDROCHLORIDE C18H20ClF3N 388.900330038 TRIFLURALIN C13H16F3N3O 335.301504183 TRIFLURIDINE C10H11F3N2O 296.201500880 TRIGONELLINE C7H7NO2 137.101500592 TRIHEXYPHENIDYL HYDROCHLORIDE C20H32ClNO 337.901504135 TRIMEDLURE C12H21ClO2 232.801500593 TRIMEPRAZINE TARTRATE C22H28N2O6 448.501500594 TRIMETHOBENZAMIDE HYDROCHLORIDE C21H29ClN2O 424.901500595 TRIMETHOPRIM C14H18N4O3 290.301504214 TRIMETOZINE C14H19NO5 281.301503117 TRIMIPRAMINE MALEATE C24H30N2O4 410.501500596 TRIOXSALEN C14H12O3 228.201500597 TRIPELENNAMINE CITRATE C22H29N3O7 447.501500598 TRIPROLIDINE HYDROCHLORIDE C19H23ClN2 314.901504006 TRIPTONIDE C20H22O6 358.401504005 TRIPTOPHENOLIDE C20H24O3 312.401500270 TRISODIUM ETHYLENEDIAMINE TETRACETATE C10H16N2Na3 361.201502203 TROLEANDOMYCIN C41H67NO15 814.002300064 TROPANYL 3,5-DICHLOROBENZOATE C15H17Cl2NO 314.201500599 TROPICAMIDE C17H20N2O2 284.401503922 TRYPTAMINE C10H12N2 160.201500600 TRYPTOPHAN C11H12N2O2 204.201500601 TUAMINOHEPTANE SULFATE C7H19NO4S 213.301600587 TUBAIC ACID C12H12O4 220.201500602 TUBOCURARINE CHLORIDE C37H41ClN2O 645.201503954 TULOBUTEROL C12H19Cl2NO 264.200210400 TYRAMINE C8H11NO 137.201500603 TYROTHRICIN C66H85N11O1 1272.502300074 TYRPHOSTIN B44(-) C18H16N2O3 308.301503100 URAPIDIL C20H29N5O3 387.501500604 UREA CH4N2O 60.101503304 URETHANE C3H7NO2 89.101503346 URIDINE TRIPHOSPHATE TRISODIUM C9H12N2Na3 550.101504167 URSINIC ACID C15H16O5 276.301500835 URSOCHOLANIC ACID C24H40O2 360.601500605 URSODIOL C24H40O4 392.600300555 URSOLIC ACID ACETATE C32H50O4 498.801800031 URSOLIC ACID C30H48O3 456.701504186 URUSHIOL (mixed enes; diene shown) C21H32O2 316.500300147 USNIC ACID C18H16O7 344.300100081 UTILIN C41H52O17 816.901504073 UVAOL C30H50O2 442.701500606 VALPROATE SODIUM C8H15NaO2 166.201500607 VANCOMYCIN HYDROCHLORIDE C67H77Cl3N8 1484.801504171 VENLAFAXINE HYDROCHLORIDE C17H28ClNO2 313.9

Page 38

Page 49: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table1

02300307 VERAPAMIL HYDROCHLORIDE C27H39ClN2O 491.100212140 VERATRIC ACID C9H10O4 182.201503662 VERATRIDINE C37H53NO12 703.800310300 VERATRINE SULFATE C32H51NO13 689.802300309 VESAMICOL HYDROCHLORIDE C17H26ClNO 295.901500609 VIDARABINE C10H13N5O4 267.201503643 VILOXAZINE HYDROCHLORIDE C13H20ClNO3 273.801500611 VINBLASTINE SULFATE C46H60N4O13 909.101500647 VINCAMINE C21H26N2O3 354.501503115 VINPOCETINE C22H26N2O2 350.500201078 VIOLASTYRENE C17H18O3 270.300310041 VISNAGIN C13H10O4 230.200300146 VULPINIC ACID C19H14O5 322.301500613 WARFARIN C19H16O4 308.300300537 XANTHOPTERIN C6H5N5O2 179.100200441 XANTHOXYLIN C10H12O4 196.201500754 XANTHURENIC ACID C10H7NO4 205.200100609 XANTHYLETIN C14H12O3 228.201501200 XYLAZINE C12H16N2S 220.300100424 XYLOCARPUS A C31H38O11 586.601500614 XYLOMETAZOLINE HYDROCHLORIDE C16H25ClN2 280.801504076 YOHIMBIC ACID C20H24N2O3 340.401500663 YOHIMBINE HYDROCHLORIDE C21H27ClN2O 390.901501199 ZAPRINAST C13H13N5O2 271.301800055 ZEORIN C30H52O2 444.701502109 ZIDOVUDINE [AZT] C10H13N5O4 267.201500615 ZOMEPIRAC SODIUM C15H14ClNO3 291.701504216 ZOXAZOLAMINE C7H5ClN2O 168.6

Page 39

Page 50: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table2

Supplementary Table 2. The 61 compounds identified from the viability screen.

ID MOLENAME FORMULA MWt02300348 1-(2-METHOXYPHENYL)PIERAZINE HYDROCHLORIDE C11H17ClN2O 228.702300329 1-METHYLXANTHINE C6H6N4O2 166.100201507 2',2'"-BISEPIGALLOCATECHIN DIGALLATE C44H34O22 914.700240584 2,3,4'-TRIHYDROXYBENZOPHENONE C13H10O4 230.200240651 2-HYDROXYXANTHONE C13H8O3 212.201501125 3-AMINOPROPANESULPHONIC ACID C3H9NO3S 139.202300336 3-HYDROXYBENZYLHYDRAZINE DIHYDROCHLORIDE C7H12Cl2N2O 211.101500105 ACETYLCYSTEINE C5H9NO3S 163.201503982 AGMATINE SULFATE C5H16N4O4S 228.301500733 ALPINETIN METHYL ETHER C17H16O4 284.302300334 AMINOBENZTROPINE C21H26N2O 322.500310004 ANABASINE HYDROCHLORIDE C10H15ClN2 198.701500135 BACLOFEN C10H12ClNO2 213.700290030 CEAROIN C14H12O4 244.201500182 CHLOROXYLENOL C8H9ClO 156.601500851 CHOLEST-4,6-DIEN-3-ONE C27H42O 382.600100615 CHUKRASIN METHYL ETHER C43H58O16 830.901500196 CLOMIPHENE CITRATE C32H36ClNO8 598.100210568 COUMARINIC ACID METHYL ETHER C10H10O3 178.201600300 CREATININE C4H7N3O 113.101500212 CYCLOPENTOLATE HYDROCHLORIDE C17H26ClNO3 327.900330025 DACTHAL C10H6Cl4O4 332.000201450 DALBERGIONE, 4-METHOXY-4'-HYDROXY C16H14O4 270.301503998 DIAZIQUONE C18H22N2O6 362.401500238 DICLOXACILLIN SODIUM C19H16Cl2N3 492.301500240 DICYCLOMINE HYDROCHLORIDE C19H36ClNO2 346.001500241 DIENESTROL C18H18O2 266.300210203 DIHYDROMUNDULETONE C25H28O6 424.500100719 DIHYDROPTAEROXYLIN C15H16O4 260.301500263 DOPAMINE HYDROCHLORIDE C8H12ClNO2 189.601500277 ERGONOVINE MALEATE C23H27N3O6 441.501500303 FLUOCINONIDE C26H32F2O7 494.501500678 gamma-AMINOBUTYRIC ACID C4H9NO2 103.101500724 GENKWANIN C16H12O5 284.301502249 GUAIAZULENE C15H18 198.301500657 HYDROQUINIDINE C20H26N2O2 326.401500772 IODIPAMIDE C12H11I3N2O 627.901504200 ISOLIQUIRITIGENIN C15H12O4 256.300300340 ISOPILOCARPINE NITRATE C11H17N3O5 271.302300228 KAINIC ACID C10H15NO4 213.201800166 KOJIC ACID C6H6O4 142.101500375 MECHLORETHAMINE C5H11Cl2N 156.101500422 NALOXONE HYDROCHLORIDE C19H22ClNO4 363.801504151 NIMUSTINE C9H13ClN6O2 272.702300345 NIPECOTIC ACID C6H11NO2 129.200300001 ORSELLINIC ACID C8H8O4 168.201500450 OXIDOPAMINE HYDROCHLORIDE C8H12ClNO3 205.601503223 PARAROSANILINE PAMOATE C42H33N3O6 675.701500642 PHENACETIN C10H13NO2 179.2

Page 1

Page 51: SUPPLEMENTARY INFORMATION · Supplementary Table 1. The Spectrum Collection (The 61 compounds identified from the viability screen are highlighted.) ID MOLENAME FORMULA MWt 01503134

Supplementary Table2

01500691 PHENTOLAMINE HYDROCHLORIDE C17H20ClN3O 317.801501109 PROBUCOL C31H48O2S2 516.900100513 PTAEROXYLIN C15H14O4 258.301500520 PYRIMETHAMINE C12H13ClN4 248.701500526 RESERPINE C33H40N2O9 608.700200851 ROTENONIC ACID C23H24O6 396.401503276 ROXITHROMYCIN C41H76N2O15 837.101503602 SALINOMYCIN, SODIUM C42H69NaO11 773.001500225 SODIUM DEHYDROCHOLATE C24H33NaO5 424.501500567 TETRAHYDROZOLINE HYDROCHLORIDE C13H17ClN2 236.701500584 TRANYLCYPROMINE SULFATE C9H13NO4S 231.301500597 TRIPELENNAMINE CITRATE C22H29N3O7 447.5

Page 2